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ABSTRACT
A series of n-alkyl carbamates been used to characterize the
role of lipophilicity in drug absorption, binding to cytochrome P4 5 Q 
and metabolism* It was found that the rate of absorption of these 
carbamates from the urinary bladder was comparable to that from the 
small intestine; it reached a plateau for the more lipophilic 
carbamates. Addition of the non-ionic detergent Tween 80 as a 
solubilizing agent reduced the rate of absorption of n-octyl 
carbamate but not that of ethyl carbamate; it was shown that 
this was probably due to the formation of an additional luminal 
hydrophilic barrier to absorption, Sargent et al, 1979; Bridges 
et al, 1979. Affinity of binding of the n-alkyl carbamates to 
cytochrome P^q in an isolated viable suspension of adult rat 
hepatocytes was found to be directly dependent upon lipophilicity.
All the carbamates gave type 1 binding spectra within one second 
of addition of substrate. Since binding to P ^ q is the first 
requisite for the oxidative metabolism of most xenobiotics, the 
latter finding suggests that rate of access to cytochrome P^jq did 
not limit the rate of metabolism.
The extent of metabolism in isolated hepatocytes was also found to 
depend on lipophilicity. No metabolism of the aliphatic group of 
ethyl carbamate was apparent whilst the higher members of the series 
gave rise to two major metabolites. These were tentatively identified 
by chemical ionization mass spectroscopy for n-hexyl carbamate after 
in vivo incubation as the (w- 1 ) hydroxylation product and its 
further oxidation product, the ketone. Covalent binding to cell 
constituents was not found.
The electron ionization mass spectra, proton nuclear magnetic 
resonance spectra and some electronic parameters calculated by 
the complete neglect of differential overlap/spectroscopy (CNDO/S) 
method were determined for the n-alkyl carbamates and some interesting 
correlations were noted. The length of the n-alkyl side chain was 
jfound to be proportional to the negative logarithm of the mass peak 
at m/e 44. This peak was shown to be due to the fragment O^C-N^H^ 
and it Is suggested that this correlation is due to the increasing 
alkyl inductive effect making the breaking of the ester bond more 
energetically unfavourable.
There was a strong downfield shift of the NH^ and methylene protons 
in the NMR spectra of these carbamates. The mechanism of this shift 
is a deshielding of the nuclei of the protons, which was predicted 
by the electronic charge density CNDO/S calculations.
Finally, a model has been proposed to explain the pharmacokinetic
data for ethyl, n-butyl, n-hexyl and n-octyl carbamates. The
essential feature of this hypothesis is that carbamate is thought not to be in
equilibrium between the peripheral and central compartments and
that hydrolytic metabolism is the exclusive concern of the
peripheral compartment, and oxidative metabolism to urinary
metabolites exclusively that of the central compartment.
Mathematics - the unshaken Foundation of Sciences,
and the plentiful Fountain of Advantage to human affairs.
Isaac Barrow.
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In deciding whether a solute is hydrophobic or hydrophilic 
reference is usually made to its partitioning between two phases, 
an aqueous and an organic one, commonly water or buffer and 
n-octan-1-o.l. Oct&nol is chosen in preference to pure 
alkanes because of its ability to accept and donate hydrogen 
bonds - a likely state of affairs in biological membranes.
The net free energy change, AG, involved in the partitioning 
of one mole of solute from an aqueous to octanol phase is:
A G  = RT InP
where P is the partition co-efficient. At a constant
temperature AG has two components: enthalpy and entropy:
AG  = H - T. AS
In the partitioning of solutes between aqueous and organic
phases, where hydrophobic effects are the major concern,
entropy change appears to be the main driving force. Small
positive or negative enthalpy changes also occur but where
these are unfavourable they are overcome by the positive
entropy change. The latter is thought to arise from the
destructuring of water molecules surrounding hydrophobic
solutes dissolved in water and Hvidt (1978) has suggested
that non polar solutes in water fluctuate between being
solvated and non-solvated. Solvation is proposed to
enhance the solubility of non-polar solutes in water:
- R + nH 0 ^ - R (H?0)n
hydrophobic ^
molecule
Association of hydrophobic molecules in water is thought 
to be due to the formation of a clathrate-like structure 
surrounding the non-polar molecules rather than to their 
direct interaction (Suggett, 1978).
There seem to be two components influencing partitioning - 
a solute-solvent interaction of the dipole-dipole type, and
being the most important (.Dunn and Wold,' 1978J® The 
importance of molecular volume for partitioning is 
demonstrated by the following graph (Cramer, 1977):
-1 -
AG-, water solution 
—$> octanol 
solution, 
kcal/ mole.
Molecular volume, A'
This is taken as evidence for a true "hydrophobic effect": 
the greater the volume of a non-polar molecule in water the 
more energetically favourable will be its loss to an organic 
phase•
When a compound is dissolved in water the solvent-solute 
molecules interact to restrict the internal rotation of the 
solute. Thus the gain in entropy on dissolving a hydrophobic 
compound in water is less than that obtained on dissolving in 
most organic solvents. As a consequence of this it is found 
that the lipophilicity of highly rigid structures, e.g. steroids, 
is considerably below what would be expected from summing the 
lipophilicity of their constituent fragments (Osinga, 1979)» 
Rekker (1977) has modified the substituent Tt-values of 
Hansch to produce a series of hydrophobic fragmental
constants- f :■ n ..
where denotes the incidence of a given fragment in the ■
structures C is a constant which depends on the solvent m 1
system used and k is a whole number. The term k C in then n rn
above equation has been found to account for any difference 
between the calculated and the measured value of log P. It 
is thought to reflect the degree of hydration or solvation 
of the molecule in question. For instance, a value of 12.Cm
has been found by Rekker for the carbamate moiety - OCO.NH^ 
by the following calculation:
f C^ H<,oCO.tJHx -* H/lv A
(fo * fco + f Hj) Toco. A/Wa ^
Eekker (1977) also discussed another aspect of hydrophobicity
during partitioning most of the energy needed is required to
create a ’’hole" in the solvent for the accomodation of a
solute. He did not say whether this may be interpreted as
the small positive enthalpy component of the partitioning
process. A whole integral number of solvent molecules is:h
thus required to vacate a .volume of space to allow in a
single solute molecule. This concept seems to account for .
the quantum (additive) nature of the lipophilicity constants
of fragments.
Some of Rekker’s hydrophobic fragmental constants, f ,
which are relevant to the carbamates are given below. All 
have been determined from partitioning in octan-l-ol: water
and they all refer to aliphatic structures:
H 0.175
0.^62H(attached 
to electronegative 
group)
C 0.15
CH 0.235
ch2 0.550
CH, 0.702
0 1.581
OH - 1 A 9 1
co 1.703
COO - 1.292
N - 2.160
m i ~ 1.825
m x - ~ 1.^28
CON ~ 2.89^
CONH - 1.970
OCO.NH ~ 1*9^3
0C0.NH2 - 1.h 81
C = 0.268 ra
An example of the importance of hydrophobic interaction in 
binding has been given by Landau et al (1977) who used a 
microcalorimeter to study the binding of a series of penicillins 
to bovine serum albumin. The various thermodynamic 
parameters which were derived showed hydrophobicity to be the 
most important determinant with electrostatic forces playing 
a secondary role. Hydrogen bonds were not formed. ?
Weiland et al (1979) have demonstrated the importance of 
hydrophobic interactions in the initial binding of agonists 
and antagonists to the - adrenergic receptor of turkey 
erythrocyteis. Antagonists bind with a small positive or 
j negative change, in enthalpy and a large increase in entropy, 
whereas agonists bind with both enthalpy and entropy having 
a net negative change. Both species have an overall net 
negative Gibbs free energy change for the binding process.
They suggested that the initial binding of the ligand to the 
receptor is the same process for both agonists and antagonists ~ 
i.e. an entropy driven event consisting largely of hydrophobic 
interaction involving the desolvation of both ligand and
or associated membrane components undergo a conformational 
change characterized by a negative entropy change (unfavourable) 
and a negative enthalpy change: an exothermic process which
drives the alteration of receptor conformation.
In the following experimental chapters it will become 
apparent that hydrophobic effects and lipid/aqueous 
partitioning are the major driving forces for the 
absorption, binding and metabolism of n~alkyl carbamates.
This brief review has sought to show some of the under- 
lying mechanisms in these events.
The transfer of comDounds across membranes
There are various ways in which a'solute or water can
cross a membrane: passive diffusion, active, facilitated 
or vesicular transport or, for water, the passive 
diffusion of water coupled to the active transport of 
some ion (local osmosis)*
In this review passive diffusion-will be discussed the 
most thoroughly since this is the process by which the 
carbamates cross all those membranes which have so far 
been studied* -
Passive diffusion occurs as a first order rate process -
i.e.’the rate of loss, dCs, is proportional to the
that all solute lost from the reservoir is absorbed and 
not bound or metabolised in the membrane.
The rate of absorption of drugs is governed mainly by 
their ionisation constants and lipophilicity. For most 
drugs the neutral molecule is preferentially'absorbed 
although the ionized species may be absorbed more slowly 
Absorption of ions may be explained by the formation of 
complexes, e.g. ion pairing; the ionized form may assume 
a conformation which conceals the charge; a greater 
surface area may exist for absorption of the ion - 
salicylate, pK^ = 3? is neutral in the stomach, pH 1*5, 
but ionized in the small intestine, pH 6.3,from where 
most of a dose of salicylate is absorbed. A further
dt
remaining concentration of solute, Cs
dt
This equation has the solution
Ct C ° exp(-k t). as
where k is the absorption rate constant, assuming a
is the existence of an acid microclimate in the small
intestine, which will be discussed later.
Houston et al (197** and 1975) and Wood et al (1979) 
found an optimum lipophilicity for the absorption of 
alkyl carbamates from the rat small intestine, i.e. a 
parabolic dependence -of absorption rate on lipophilicity. 
They proposed that this optimum existed because of the 
presence of both hydrophilic (e.g. the glycocalyx and 
unstirred layer) and lipophilic (the lipid, membrane) 
barriers. The optimum absorption rate occurred when 
the solute was able to pass most rapidly through the 
combination of these two barriers in series. Partitioning 
of the solute from the bulk solution in the lumen into 
these barriers is therefore very important.
To support this proposal it was found that the absorption 
of carbenoxolone is much preferred when ionised (Bridges 
et al, 1976). The neutral molecule of this drug is , 
extremely lipophilic - ionization will decrease the 
lipophilicity and thereby facilitate absorption.
It should be emphasized that there are other explanations 
for this parabolic relationship: Penniston et al (1969)
proposed that it could be caused by the alternate 
partitioning of solutes between a series arrangement of 
a multiplicity of organic and aqueous phases, and this was 
confirmed experimentally by Dearden and Patel (1978).
They also found that a very long time was taken to achieve 
equilibrium. Winne (1978a)showed that the absorption 
rate of very permeable solutes could apparently be decreased 
by their being subjected to a venous - arterial shunt in 
intestinal villi which are being slowly perfused with 
blood. This model will be presented in more detail later.
(a) Lucas et al (1976) and Lucas and Blair (1978) used pH 
microelectrodes to measure the pH adjacent to the mucosal 
wall along the length of the rat small intestine and 
found a surface pH of approximately 3*5 in the upper 
jejunum which increased towards neutrality in the distal ileum 
This'pH was dependent on the presence of glucose, oxygen
and Na+ in the bathing medium. The Authors quote 
thiamine and folic acid as owing their absorption to the - 
presence of the acid microclimate. Breakdown of the 
glycocalyx, which the Authors consider to stabilize the 
acid microclimate against dilution by the more alkaline 
bulk phase of the luminal solution, has been shown to 
be associated with folate malabsorption (Swanston et al,
1977; Lucas et al, 1976a+b). Similarly, compounds which 
increase the microclimate pH (e.g. ethanol, diphenyl- 
hydantoin, and methotrexate) decrease the absorption of 
folate (Lucas et al, 1978).
(b) Unstirred layers of solvent exist next to the mucosa, 
due to the incomplete mixing of the luminal bulk phase, 
which result in the underestimation of permeability 
coefficients and overestimation of Michaelis - Menten 
constants (if active transport is involved). The width 
of this layer has been measured and for the rat small 
intestine in vitro is 180 - 220 i^m (unstirred) or
1^0 - 160jxm (stirred). For the in vivo rat jejunum 
the layer is about kZOjim (Winne, 1978b). Winne et al 
(1979) showed that by reducing the unstirred layer in 
the perfused rat jejunum the Michaelis - Menten constant 
for the transport of phenylalanine fell by about half 
compared to the value measured in unmixed perfused rat 
jejunum. Winne (1978 b) similarly demonstrated an
antipyrine). The following relationship describes 
how the true permeability of a solute (P^) varies with 
the observed permeability Presence 311
unstirred layer of width 8 :
1 1  + 8
Where D is the diffusion constant of the solute in 
the luminal solution. (The reciprocal of the
permeability coefficient can be thought of as a measure
of the resistance to transport).
Winne (1978c) describes how to correct measured
permeability coefficients for permeation of a solute
across a villous membrane (e.g. the small intestine)
over which an unstirred layer exists.
(c) Winne (1978a) has reviewed the various models
describing the variation of intestinal absorption with
blood flow rate. Most of these models show a similar
relationship between absorption rate and blood flow rate:
Appearance 
in venous 
blood.
highly
permeable
solute
solute 
with low 
permeability
0 Rate of blood flow.
from the luminal bulk phase to the interstitial space
near the capillary wall (includes the unstirred layer,
glycocalyx and intestinal epithelium) and then through
the further barrier of the capillary wall. It is
assumed that the solute is not bound or metabolized in
the intestinal wall and there is no solvent drag. The
rate of permeation is then:
• 0 = CT - C inole/min/gm wet weight tissue_L________ pwa
1 4- 1; \
PB1^B1 ocalVBEl
where:
CL is the solute concentration in the luminal bulk phase 
(mol/litre).
C is the solute concentration in the arterial pwa
plasma water (mol/litre).
is the permeability coefficient of the first
barrier (cm/min).
Afii is the area of the first barrier related to wet
tissue weight (cm /gm).
oc is the fraction of the total blood flow rate in
the capillaries near the epithelium.
a^ is the ratio of the solute concentrations in
blood/plasma water.
Vg is the total blood flow rate of the intestinal
loop related to tissue wet weight (ml/grn).
E = C - C 1 pwv pwa
CT - C I pwa
0^ is the solute concentration in the interstitial
space near the capillary wall (mol/litre).
C is the solute concentration in the venous plasma pwv *
water (mol/litre).
- o ; xs une driving lorce i or iransier w n n e  L pwa °
1 and 1
rr— . -- rr-r=; represent the resistance to transfer
PB1*B1 aal B 1
presented by the two barriers. The absorption rate 
constant for a one compartment open model is related to 
0 as follows: 
k = 0. W 
~*L
where:
W. is the wet tissue weight of the intestinal loop (gins}.
is the volume of the compartment (mis).
For very highly permeable solutes a counter current 
exchange between venous and arterial blood may occur so 
that at low blood flow rates the appearance in the venous 
drainage may be lower than would otherwise be the case:
Appearance in 
the venous blood
Rate of blood flow.0
A partially closed loop of recirculating solute is 
thus set up in the villi and the permeation rate
CL -
Cpwao
1 + >  + PeAeEl
*81^1
j C v X
\ x alVB
aalElVB
where:
pwao = CpWa before entering the exchange region
P is ihe permeability coefficient of the exchange 
e (cm/min)•
A is the exchange area related to wet tissue weight 
e (cmVgm).>
As already mentioned this phenomenon may explain why
i
the absorption rate of the highly lipophilic alkyl 
carbamates appears to decrease (Wood et al, 1979)*
(d) Solvent drag may occur under conditions in which 
a drug is being absorbed from a hypotonic solution.
This is thought to be due to the presence of pores in 
the membrane through which water is absorbed, this 
volume flow carrying with it solute molecules (this is 
not to be confused with the solute - solvent interaction 
occuring in membranes as described by Kedem and 
Katchalsky, 1958; and Van Zoelen et al, 1978 a + b).
It has been shown by Kitazawa et al (197^) that the
absorption of sulphanilamide and metoclopramide was 
enhanced by concurrent water absorption and was decreased- 
by water flow from blood to gut lumen. Kojima et al 
(1972) accounted for the change of rate constant for the 
absorption of sulphaethidole from a hypotonic solution 
in the rat small intestine by correcting for volume 
change and absorption area. It has been found that the 
absorption rates of n-alkyl carbamates from the rat 
colon are not affected by simultaneous high rates of 
water absorption, and it was concluded that the colonic 
pores must be small compared to those in the small
Fordtran + Ingelfinger (1968) found evidence for a 
gradient of water pore size along the small intestine, 
the pores being widest in the proximal jejunum, and 
Wheeler et al (1978) came to a similar conclusion, 
based on the absorption of some hydrophilic inert 
sugars from the human intestine. .
Ficks Law has been found to be inadequate to describe 
the passive permeation of solutes across membranes . 
because it ignores the co-diffusion of solvent (usually 
water) with solute and the interaction of these two 
species within the membrane. Kedem and Katchalsky 
(1958) provided a more detailed analysis and derived 
the following expressions for an ideal two component 
system (i.e. one solute dissolved in pure solvent):
Jv = Lp(AP - CRT. ACb)
ft = C L  (1 - <J)Ap + [w - c L (i-<j) ct] rt.a cs s p * L . s p J s
n =£JRT. A c  + (1-CT) G* J
S S S V
where:
Jv is the total volume flow per unit area
n v + n v
W W S B
V is the partial molar volume of solute
(subscript S) or solvent (subscript W)
n is the flow of solute or solvent into the inner
compartment (i.e. across the membrane) per unit area::
= 1. dN 
A dt
L is the hydraulic conductivity or filtration constant. 
P
A p  is the hydrostatic pressure difference across the 
membrane•
(X is the reflection coefficient - 1 4 -
R is the gas constant 
T is the absolute temperature
AC is the concentration difference of solute across 
s
the membrane.
C is the mean of the concentrations of solute in the 
s
inner and outer compartments.
U> is the solute mobility. At zero volume flow
P = toR T 
s.
where Pg is the more familiar permeability
coefficient (Kedem and Katchalsky, 1961; Painty
and Ginzberg, 1963)-
In the presence of non-permeant solutes on at least
one side of the membrane there is an additional driving
force to the flow and the equations become:
J = L (Ap -Arq) - o-l (RT. AC + m  .Art) v p •. p s 7s ^
A = L (1 - CT).C (Ap - Ar^) + fa -ffL (1-CJ). C_1 (RT AC +00.&7X-)£ P S p SJ 0 to
n c = J (l-cf). c + 6j(rt. A c  +a> A n t) ^ T S S rs
A r t L is the contribution of the non-permeable solutes
to the osmotic pressure difference.
ffl is the volume fraction of solute = C V.
Ts S B
L is analogous to water permeability if no permeable
solute is present or if it is at equilibrium across the 
membrane (compare withcjRT).
The degree of interaction of solute and solvent within 
a membrane can be inferred from the value of Cf :
L
P
As 6 — > 1 - o>% the two flows can be considered to 
l-P
be occuring independently whilst O' — * 0 indicates free 
diffusion, i.e. a non-selective membrane completely 
permeable to any solute.
The relation between <S and P is as follows:s 
O' = 1 - P I V - K.fsw
S S . — —  ___ __________
RT.L^ y)w* ( |* So + f inw)
where:
K is the membrane: solution partition coefficient 
f is the friction coefficient for solute-solvent (SW), 
solvent membrane (SM) and membrane-solvent (MW).
This relationship is shown graphically for various drugs 
crossing the wall of the rabbit gallbladder;
1.0 n
<r, reflection 
coefficient.
0.5-
10
P V cm /sec/mole x 10 
s s
The mechanism of passive transfer through a membrane 
has been investigated theoretically by Barnett and 
Licko (1977) using a kinetic analysis of three 
compartmental models - namely, a homogeneous tissue
model (i.e. two barriers in series with an additional 
transport route (the pore) in parallel) provided the 
best explanation of how salicylate anion crosses the 
isolated rat jejunum. The unstirred layer was not 
considered important in limiting absorption despite 
the requirement for an extraepithelial barrier to 
adequately describe salicylate transport, which does 
not occur by solely passive means.
Van Zoelen et al (1978 a + b) showed that there is a 
co-permeation of water with solute molecules across 
the membranes of lip os cirtes (as described in the volume 
flux equations of Kedem + Katchalsky, 195&) which was 
independent of temperature or the nature of the (non­
electrolyte) solute but was dependent on the osmotic 
concentration of impermeants inside the liposomes.
In the system that they used, in which 20mM glucose 
was trapped within the liposomes, the ratio, N, of the 
number of molecules of water per molecule of solute 
which permeated the membrane was equal to the ratio,
R, of water to impermeant solute molecules inside the 
liposomes, i.e. 2500 - 3000. The driving force for 
permeation is an increase in entropy: the activation
energy required to dehydrate the solute to introduce 
it into the hilayer - this was thought to be the rate 
limiting step in absorption. Maximum entropy occurs 
when N = R because under this condition no osmotic 
difference is induced across the membrane. Within
the bilayer the solute is contained in cavities between 
the fatty acid chains of the phosphatidylcholine
maximum value of N is correlated with membrane fluidity - 
the packing of lipids in the bilayer - and depends on the 
ability of the bilayers to form cavities. Incorporation 
of cholesterol could only be accomplished in liposomes 
containing well saturated lipids but when this was done 
a closer packing of the lipids was observed along with 
a greater activation energy for the permeation of water and 
solute.
2). Active transport: this is an energy dependent 
process taking place against a concentration gradient.
It is responsible for the transport of Na and K. to 
'create a potential difference across cell membranes and 
the uptake of some nutrients from the gut lumen and 
across cell membranes. It has many of the properties 
of enzyme reactions and can be described by the 
Michaelis-Menten equation:.
1 = K . 1 + . 1
v fCl Vmax max
When the system is saturated the kinetics become zero 
order - i.e. rate is independent of substrate 
concentration:.
d [S] = Vu . max
dt
Fletcher (1976) has provided a phenomenological 
description of active transport analogous to that 
derived by Kedem + Katchalsky (195&) for the passive 
transfer of non-electrolytes.
3). Facilitated diffusion is a spontaneous downhill 
transport which does not use energy, is not linearly 
related to the electrochemical potential of the substrate,
some amino acids, short chain monocarboxylates and D- 
glucose in cerebral capillaries.
Another characteristic is that of flux interaction or 
exchange diffusion: increasing the concentration of 
substrate on one side of the membrane will increase the 
flux of this substrate across the membrane in both 
directions.
This type of transport has been ascribed to carrier 
molecules in plasma membranes, conformational changes 
in membrane proteins or diffusion through specific 
pores or channels. Pores in the human erythrocyte
, C
membrane have a diameter of about A, and m  the
o °cerebral capillary endothelium oA. Transport through 
such pores is limited to small non-electrolytes, e.g. 
urea and methyl carbamate, cL may have their rate of 
absorption enhanced by solvent drag. There are other 
explanations for facilitated transport through pores
(Rapoport, 1976):
(a) a homogenous model membrane without pores accounts 
for the size dependency and pattern of non-electrolyte 
diffusion::
Permeability is proportional to partition coefficient x s]lA. W.'
(b) Permeabilities in synthetic bilipid membranes 
without pores correspond to those in natural plasma 
membranes. The relationship between simple and 
facilitated diffusion is shown below:
0 Solute concentration,
Jf) Vesicular transport is responsible for the passage 
of protein and other large molecules across capillary 
walls and plasma membranes. It is passive and 
bidirectional; the only energy involved is that needed 
to keep the integrity of the cell membrane and maintain
its turnover rate. It takes place by the invagination 
of the cell membrane t^iorm a vacuole containing the 
high M.W. molecules or particle to be transported.
‘......  ~ " '...........g 2
Transport rates of about 7 x 10 vesicles/sec/cm are 
found across the endothelium of muscle capillaries 
(Rapoport, 1976).
5). Water transfer: Many models have been proposed to 
describe water absorption and these have been reviewed 
by Hill (1977)• All involve the active transport of, 
usually, Na+ , coupled with the osmotic transfer of water.
Two of these models are described below:
(a) Gupta et al (1978) measured Naf , K+ and Cl” 
concentrations in frozen sections of epithelial 
mucosa of the rabbit ileum by electron microprobe X-ray
space's. Water is then absorbed from the lumen 
across the tight junction and an absorbate appears 
on the basement side of the epithelium:
1TJMEET EPITHELIUM SEROSA
ETa
lateral intercellular 
space
tight — ■ 
junction
basement membrane
The width of the lateral intercellular space increases 
with the rate of transepithelial fluid flow (Spring and 
Hope, 1978).
(b) Curran and Macintosh (1962) showed how a coupled', 
double membrane system could transport water::
cr>0 or=0
The reflection coefficient Cf.~ >0 and so an osmoticAB
B is a closed compartment and the membrane B - C has 
wide pores: 0 , therefore there is no osmotic
•DO
pressure difference across B - C.
A hydrostatic pressure is thus generated in B and the 
solution in B is driven almost exclusively into C due 
to the relatively wide pores in BC compared to those 
in AB, which offer a high resistance to volume flow.
In this way, as long as B is hypertonic with respect to 
A fluid can flow from A to C regardless of the tonicity 
of C. Fluid can therefore appear to flow against 
an osmotic pressure gradient.
These two models are perhaps complementary, depending 
on the relative sizes of pores in the tight junction 
and basement membrane. The lateral intercellular space 
would then be analogous to compartment B.
In chapter 3 it will be shown that passive diffusion 
is the method by which the carbamates permeate the 
bladder wall. This review on the transport of solutes 
across membranes has attempted to demonstrate the 
processes underlying this permeation.
modelling of rates of drug dissolution, absorption, 
distribution, metabolism and excretion.
Several methods for this type of modelling have been 
introduced, in particular the use of compartmental models 
with their concepts of rate constants for distribution 
between plasma and tissue, volumes of distribution and 
clearance rates. Recently, anatomical models have been 
proposed which consider flow through each type of tissue 
or organ and the partitioning of the drug between the 
blood and the perfused tissue. For example the 
pharmacokinetics of methotrexate (Bischoff et al, 1970)
' . ■ i
thiopentone (Bischoff and Dedrick, 1968), cyclocytidine 
(Himmelstein and Gross,1977) and mercaptopurine 
(Tterlikkis et al, 1977) have been characterized in this 
way.
This review will concentrate on the compartmental 
description of drug distribution and in particular the • 
two-compartment model which Wood (1977) used to 
describe the pharmacokinetics of n-alkyl carbamates in 
the whole rat.
Tissues can be separated into three main groups 
depending on the blood flow rate through them:
(a) profusely perfused organs: heart, CNS, kidney,
GIT, liver + endocrine glands - 9% body weight gets 70% 
cardiac output.
(b).(i) skin + muscle - 50% body weight
(ii) adipose tissue + bone marrow - 19% body weight. 
These two sub-groups are comparably perfused but 
separable by their solvent characteristics.
(c) poorly perfused tissues: bone, ligaments, tendons,
fitted to the plasma conc. v. time profile for a drug, 
the most common being the two compartment model consisting 
of a central (plasma) compartment + a perfused tissue
compartment; .
log plasma
V
i
Time.0
That is, the time course of the presence of a drug 
in the body can be described by two first order processes; 
an oc (distributive) phase + a jS (elimination) phase;
Some drugs do not conform to the 2 - compartment model — 
their half life increases and ^decreases as the dose 
is increased i.e. the pharmacokinetics are dependent 
upon the dose of drug given. Dayton et al (1967)
found this to happen with phenylbutazone and proposed 
that this was due to the progressive inhibition of its 
own metabolism as the dose was increased. Nagashima. 
et al (1968) explained the dose - dependent kinetics 
of bishydroxycoumarin in man in a similar fashion, 
fitting the plasma level data with a 3- compartment
compartment for — ^  ---  compartment
metabolism 12 31
k20 „ ~ -nt . -oct u -fitCp = Pe + Ae + Be^
I
elimination
Dose dependent kinetics are also known for diphenylhydant 
+ probenecid. Possible explanations for this behaviour, 
besides metabolic inhibition, are changes in distribution 
degree of protein binding or urinary excretion of 
unchanged drug with changing plasma levels of the drug.
However, to return to a discussion of the 2 - compartment
model, the equation describing GT. as a function of
P
time in the above graph is: *
+ (Gibaldi et al 1969)
C = Ae” + Be“r 
P
and the drug concentration in the tissue compartment (C,)
w
varies with time as follows:
C* = A + B« - e-Pt y  (Ba01' 1971)
cc - p
Various rate constants can be derived from these 
equations (Gibaldi et al, 1969 ; ( M&yer&ohn & Gibaldi, 
1971):
k£^ = Ap + Bod
A + B
k:el “
k21
k12 ” * + ^  “ k^21+ kel^
& - fc fc = fraction of drug in
* ' the central
compartment during 
the p phase.
These same parameters have been estimated from post 
infusion plasma levels of drugs by Singhvi (1977).
The total volume of distribution at steady state is:
Vdss = vc-(k1 2 + ^
k?-l
Gibaldi et al (19&9) have criticised the use of this 
constant because it only represents the total amount of 
drug in the body (V^^.C^) at the instant when rate of
drug entry into tissue equals the rate of drug entry into
plasma from the tissue. At other times total amount of
drug in the body is either overestimated (before steady
state) or underestimated (after steady state). They
proposed the use of V^,the volume of distribution during 
j^audoequilibrium, i.e. the p phase:
V. = V k . = V dp c el c
~ T ~  71
Volume of distribution may be thought of as that volume 
of solvent in which the drug would have tobe dissolved toA
attain a concentration equal to that in the plasma.
/
The area under the C. v.t curve (AUC) can be calculated
P
as follows:
t s
AUG: = f (Ae""* + Be"?*5 .it
J t = o
= A + B
a  J
Comparison of AUC following i.v. injection with that 
following any other route of administration will give 
the fraction of the dose available to the systemic
AUU .IV
This ratio may be less than one for a number of reasons
e.g. incomplete absorption or the first pass effect. 
After any route of administration other than intravenous 
the amount of drug absorbed after time t (A^) is:
A. = c: V , Yt p c + +
amount .amount
k . V C'.dt el c p
_ _ ------ ° amount of drug
o rug drug excreted,
m  central , .. . m  tissuecompartment
and when *fc - 00 z. M
A = k . V, 
00 el c C .dt: p
o
Total plasma clearance (i.e. the plasma volume/min which
is completely cleared of drug by all the elimination
processes acting in concert) is:
D
AUC
The rate of excretion of a drug into the urine is
^  = Ku Mt .-.Ut = Ku. M0(l
dt = K„. K0 e ~k^
This is for a one compartment process: during the
elimination phase of/a 2 - compartment process 
£ can be substituted for e; or, for the whole
time course of a 2 - compartment process can be
replaced by (= Ae”0^  + Be
As t go :
~ Ku . M Similarly / d
k o
k w
\ ]
If the total urinary excretion of drug is known, k ^
This is the ‘sigma minus'method for estimating k ^
(Martin, 1967). k can similarly be determined from
urinary excretion data;'
dU = k V C  • ■ • ex c p
dt
cm. A x£).
= k V (Ae'** + Be P )ex c
-fit-
Therefore a semi log plot of urinary drug excretion v.t
will be biexponential with the same cL and p gradients as
in the plasma profile but with intercepts of k V Aox o
and k V B, ex c
The decline of a drug from a depot usually follows first
order kinetics;:
M, = M e 3 M = amount of drug in depot
0 0 at t = o (=D). k = absorption
rate. a
The rate of change of plasma concentration of M is ;
dM = k M e~k3.^  - k . M
dt a ° Gl
* C = FD k (e~k©fc -t- e”^ )
* P . a -
V (k - k .) c a el
k and k can be calculated by the following method; 
a el
Dk
el
log C
0 Time.
k must be at least 2k n (Bacq,1971). When k <k n k „ a el a el, el
becomes the gradient of the feathered line and k& the slope
of the terminal line. This is the "flip-flop" phenomenon 
and kel> 2ka for validity (Bryon'+ Notari, 1976).
The kinetics of multiple dosing + plateau levels 
following continuous intravenous infusion have been 
dealt with by Wagner et al (1965)* Goldstein et al (19&9) 
Cucinell + Perl (1970) and Bacq (1971)*
Rowland et al (1973) have studied the clearance of drugs 
in isolated perfused organ systems (taking the liver as 
an example) and found that this model parallels the two 
compartment whole animal model:
kel
ELIMINATING  ---------- > M
Vb
V
RESERVOIR CL ,V 1 r
Co
vb
cl1 = conc. of drug in reservoir
c0
_  11 tt
V-
/
v leaving organ
ce
_  II If 11 in organ
Ve = volume of organ
Vr = volume of reservoir
vb = blood flow
E = amount of drug in organ
M = amount of drug eliminated
c. = c:
p'v
b _ \  + Km - * C
e"Kt +
P* v , )
m
- 06 DC - /»
(N.B. This equation is analogous to G = Ae +
P
c = crO 1 (-fc)
- 06
.(e
' —cct - e ■pt).
where :
06 >* ft = V, + ’ V, + K r b b
r \
and ccf = hj< m
V
The mean clearance V ^ is the average volume of blood 
cleared of drug in unit time:
cl DATJC
= vb Km P' y
Vt, ;+ Km f' Ve
This relationship is the same whether the drug is 
introduced as an instantaneous injection or is infused 
until a steady state (plateau) is reached (i.e. infusion
rate equals elimination rate).
The pharmacokinetics of a drug can be affected by three 
main factors: the first pass effect, protein and tissue
binding + the enterohepatic circulation:
1. First pass effect:
This occurs when a drug is rapidly metabolised or 
otherwise sequestered between being administered and 
being available to the systemic circulation. The liver 
+ lung are the two organs which are largely responsible.
kinetics of these drugs before and after the construction 
of a portocaval shunt. They found that the availability
of lidocaine rose from 15% to 8l% and that of
salicylamide from 22% to 58%. A possible explanation
of the low availability of salicylamide even after a 
portocaval shunt is provided by metabolism in the intestinal 
wall and trapping in the stomach wall (Brune et al 1977).
George et al (1976) have shown that propranolol is %
extracted to the extent of 69 - 92% during its first 
pass through the liver in dogs.
Chiou (1975) has quantified the extent of hepatic and
pulmonary first pass theoretically:
K' = K + K + Kel m p r
K _ = Overall first order elimination rate constant el
K = first order metabolism rate constant m
= first order rate for pulmonary excretion
K = first order rate for renal excretion r
f = fraction of dose metabolised in liver during each passage
f = fraction of dose excreted from lung ft 11 11
P
/
Fraction of dose metabolised in infinite time is:
F = f + (1 - f ) (1 - f ). K m m  m p m
Kef '
and Fp = (1 - fm) fp + (1 - fm ) (1 - fp ) Kp_
K „ ef
Hepatic clearance = Km Vc ,= f HFE. HFE = hepatic blood flow rate
Pulmonary clearance = K^Vc= f^ PFR. PFR = pulmonary blood flow rate
Total body clearance = K , Vel <
Chiou (197*0 has also looked at the elimination of a 
fluorocarbon following i.v. administration in the dog. 
These compounds are very volatile, inert and have a 
low solubility in the plasma and during their first pass 
through the lungs are lost to a great extent (by 
exhalation of the vapour, not metabolism). Following 
i.v. administration the fraction not eliminated is f and
= f . D f = 1 - PC PC ,= pulmonary
■f:
ft. AUC PFR clearance
Total clearance = V, t. A
df I
.'•PC = fch
where f , = (total amount of compound exhaled) - D(l-f)
f. D
(i.e. the fraction of the amount of compound in the 
general circulation which is exhaled from the lungj 
=1 for compounds eliminated exclusively by this route). 
For dichlorotetrafluoroethane Chiou (197*0 found that 
the plasma data were./ fitted by a 3 compartment equation 
and 82% of the dose was exhaled during the first pass 
through the lungs. V, c was about eight times body
dP
weight, showing great localisation in some tissues. 
Rowland (1972), Rowland et al (1973) and Gibaldi et 
al (1971) have also studied the first pass effect and 
found that:
F = AUC = 1 - V ,
AUC. ~i.v. V,b
for an isolated perfused organ. In the whole body
(k21 + kel)
or, if the first pass effect is due to the liver:
F = 1 - D_______
AUC. HFRi.v.
when the drug is administered into the peripheral
compartment - e.g. by injection into the hepatic portal vein.
2. Protein binding: A huge number of drugs are protein
bound in blood, mainly to serum albumin - for examples
see Goldstein et al (1969). Kurz et al (1977) bave
compared four much used methods to estimate the degree
of protein binding of drugs. Protein binding markedly
affects the disposition of drugs since it is only the
unbound or free fraction of a drug which is available
for diffusion into tissues or interaction with receptors
(Shoeman + Azarnoff, 1975)* If the drug is strongly
bound (and dissociation of the complex is therefore slow)
it may be expected to have a long half life: an extreme
example of this is suramin (a trypanocide) which remains
effective for three months after a single oral dose.
Eoosdorp (1977) has tried to characterise the binding
of some compounds to/ human 'serum albumin (HSA): there
appear to be two main binding sites - one for bilirubin
which appears to require a positively charged lysine
residue and a separate site on the same molecule for
binding benzodiazepines (e.g. diazepam, chlordiazepoxide
+ nitrazepam) and some non steroidal anti-inflammatory
agents (e.g. salicylate, phenylbutazone + indomethacin)
which needs a positively charged arginyl residue.
Less specific binding can occur involving Van der Waals
forces, hydrophobic attraction, dipole interaction etc.
relative concentrations, apparently by an allosteric 
mechanism. This is supported by Sjodin (1977) who 
suggested that the binding of free fatty acids by HSA 
is probably accomplished by local changes in the 
conformation of HSA. Faerch ■+ Jacobsen (1977) found 
that bilirubin binds to HSA in a complex series of 
reactions: first there is a very rapid second order
association of the two molecules followed by four first 
order processes taking place in five steps to produce 
the" complex which is found at equilibrium.
Coffey (1972) showed that the area under the plasma 
conc. v. time curve can still be described by the 
classical equation if the plasma conc. of free
(unbound) drug ^pf) °nly is -considered:
f t= 00
C dt
, p t=o
Martin (1965) and Coffey et al (1971) demonstrated the 
variation of plasma protein binding with total plasma 
concentration of drug. The constant of association 
between drug (D) and protein (P) is:
Kap = M
The fraction of drug which is free is:
oc = - v  + tDfi
p t) p
Cpt] + KdP + lDf)
f = free 
t = total
K_ = dissociation constant = 1aP ~
ap
[Pt) = 5 x 10 \  in normal humans.
r (Et) + Kdp + *' pf]
Pedersen et al (1977) have shown how drug-protein
binding parameters can be obtained from dynamic
(i.e. non- equilibrium) dialysis data.
Usually, - dD = k -,.D but for drugs having a high K
at 01 ap
(i.e.^ 1 0  ) k ^  will decrease and t^ increase as first
order elimination proceeds because an increasing
proportion of the remaining drug will be protein bound.
Therefore a constant relationship will only exist if the
C „ alone is considered, as mentioned above: 
pf
- dD = V. D 
dt
Gibaldi and McNamara (1977) have suggested a mehtod of 
determining the fraction of unbound drug (f.) in the tissue
w  /
compartment:
f . = V. f t t p
V,A- V d£ p
f = fraction of drug free in plasma 
V = plasma water volume
/
= volume of total body water minus plasma volume.
v
They used this equation to find the changes in tissue 
binding of phenytoin between control, nephrotic and 
uraemic people and between low or high plasma binders 
of warfarin in rats. In humans both diseases caused 
a doubling of and f^ while f^. was not affected.
In cases of nephrosis f was increased, due probably
to the hypoalbummaemia which occurs in this disease, 
and in cases of uraemia binding was decreased, perhaps 
by displacement of phenytoin from the binding sites by
3. The enterohepatic circulation: A number of
exogenous + endogenous compounds are recirculated and 
their half lives extended and plasma levels maintained 
as a result of this process:
CIRCULATION
LIVER
Bile
v
f a e c e s:
There are a number of requirements for the significant 
biliary excretion of a compound to occur (Smith 1973)?
In the rat there is a MW threshold of 300 - *f00 above 
which biliary excretion generally becomes marked (i.e.>10%) 
There appears to be an upper limit, thus inulin (MW 3000)
+ certain azo dyes (Congo red, Evans blue, Trypan blue) 
which form high MW aggregates or are protein bound in 
plasma are poorly excreted in bile.
The substitution of phenyl, cyclohexyl or heterocyclic
/ . 
groups into some compounds which are poorly excreted in
bile considerably enhances their biliary excretion
although the resulting derivative may be well below the
MW threshold.
A linear correlation exists between log P (range of P =
0.0003 - 0.2930) and % biliary excretion for a series 
of monoquaternary ammonium compounds (Hirora et al 197^)• 
Acids with pK 1 s < 5  (e.g. conjugates of glucuronic acid,
I S,
glycine, cromoglycate or phenolphthalein disulphate) and 
strong bases, all of which are ionised at pH 7»^*are
role is as yet ill defined. Shifting the SO^ group
around in a number of sulphonated dyes caused a k - 8 
times chiange in the extent of their biliary excretion; 
there is a big difference in the biliary excretion of 
the azo dye Ponceau SX and its structural isomer Scarlet 
GN and similarly between the glucuronides of *f-hy dr oxy biphenyl 
and if,^  - dihydroxybiphenyl. This difference may be due 
to a change in lipophilicity, molecular conformation or 
the relative intra molecular relationships of the 
hydrophilic and lipophilic groups.
There seems to be a specific uptake process for the 
transfer of organic anions from the plasma-*hepatocytes: 
compounds which are excreted extensively in the bile are 
often concentrated against a large bile plasma gradient,
i.e. 10 - 1000. Four possible mechanisms have been 
advanced to explain this.
(a) Active transport - this certainly occurs for bile 
salts and conjugates of bilirubin.
(b) The formation of a primary bile which is modified by
the reabsorption of water and small ions and molecules
/
as it passes along the bile duct. In this way large 
molecules (MW >300 - *f00) would be trapped and concentrated 
in the bile.
(c) Micelles consisting of bile salts, phospholipid and 
cholesterol can form in the bile; some drugs may be 
incorporated into these so allowing diffusion of more of 
the free (unbound) drug into the bile.
(d) Back and Calvey (1972) suggested that the biliary
I kexcretion of C - edrophonium may take place by the 
transfer of this drug directly from blood to bile jn
vessels are adjacent to branches of the bile duct,
Hirom et al (1976) studied the excretion of some 
compounds in the urine and bile and found that in the 
range of MW 35P ~ **50 compounds were significantly 
excreted via both these pathways and that blockade 
of either one (by ligation of the bile duct or renal
pedicles} increased the excretion of the compound via
the other pathway. Compounds with MW >**50 or . <350
"V
were excreted mainly in the bile or urine respectively 
and in either of these groups blockade of either pathway 
did not cause a complementary increase in the excretion 
of the compound via the remaining route.
It can be seen from the foregoing description that
the apparently simple relationships between the 
variations in plasma concentration of a drug with time 
after its administration is really a composite function 
of a number of complex interacting and competing systems.
The properties of simple esters of carbamic acid have 
been reviewed by Adams and Baron (1965)* They are 
generally synthesised by the reaction of urea with the 
appropriate alcohol, e.g.
Me* CHOB + (NH_)~ CO ------> Me* CHOCONH '+ NH
d d d d d $
Carbamic acid is so readily hydrolysed that it cannot 
exist in aqueous solution (it instantaneously 
decomposes to CO* + NH ) but its organic esters are 
fairly stable (Kuhr and Borough, 1976).
The stability of carhamates against hydrolysis of the 
carbamate hond is in the order - 0C0NH2 <  - OCONHMe <  - OCONtAe^ 
and this correlates well with the electron 
density around the N atom. Electron with-drawing 
groups (e.g. as in nitrophenyl carbamate) destabilise 
the carbamate groups. The following are the second 
order rate constants for hydrolysis of phenyl N- 
substituted carbamates determined in barbitone 
buffer, 0.1M, pH 9-5, 37*5° C (Kuhr and Dorough , 1976).
N - Substituent ^Sayd ^mo^e ^ m^n
C6 h5 ; 3800
CH2C6H5 r 820
C_H 300
CH_ 230 V
3
Even greater stability is obtained with N,N - 
disubstituted carbamates:
increasing stability
increasing stability
N, N - di He
N, N - di Et
N, N - di n-Pr
N, N - di n-But
N, N - di iso-Pr
There are two mechanisms for the alkaline hydrolysis
of carbamates:
R.O-C.N Me, 
II 
0
+ OH
0
I
ROCNMe.
i ‘
OH
ROH + Me NCO
Me0 NCO 
II
+ H20 •Me- NCOH + OH
2 II
Me^ NCOH 
2 I
Me2. NH + C02
2. Aromatic methyl + unsubstituted carbamates:
ArOCNHMe + OH 
II 
0
ArOCN Me 
I 
0
+ h 2o
ArOC = N M e
ArO~ + M e C N O
Me.CNO + H20 MeNHCOOH MeNH2 + C02
Houston (1973) found that a homologous series of aliphatic 
straight chain N-unsubstituted carbamates were resistant 
to hydrolysis in aqueous solution for at least 48 hours.
Uses of carbamates: Despite its carcinogenicity,
i
urethane (ethyl carbamate) is widely used as a laboratory 
anaesthetic and is a mild diuretic. Other carbamates 
are used clinically as hypnotics and tranquillisers 
(e.g. hedonal, aleudrine, aponal and meprobamate); as 
(centrally acting) muscle relaxants and analgesics 
(carisoprodol and chlorphenesin); and as anticholinesterase, 
agents in the treatment of glaucoma, myaesthenia gravis, 
gut atonia and in the protection of AchE from irreversible 
poisoning by organophosphorus nerve agents (e.g. 
neostigmine, physostigmine and pyridostigmine). Their
the enzyme:
HAchE + XOCNHMe HAchE. XOQNHMe  — >  AchECNHMe + HOX
I II I
0 0 0
AchECNHMe  -----^  HAchE + MeBHCOOH
II *
0 MeNH_ + CO_
■ *- c.
'This reaction is complicated by the fact that the 
presence of excess carbamate reactivates the 
carbamoylated AchE. The kinetics of the complete 
mechanism have been worked out by Watts and Wilkinson 
(1977)• Abdel-Aal (1977) has studied a series of 
in-substituted phenyl N-methy1 carbamates and suggests 
that the relative lipophilic and electron donating 
properties of the substituents increases the anii-Ch£ 
potency of the molecule by increasing its ability to 
form a complex (i.e. non-chemical binding) with the 
enzyme rather than by increasing its ability to 
carbamoylate AchE, this complex being a necessary 
preliminary step in the carbamoylation of AchE by 
carbamates.
Because of their ant^-ChE activity some carbamates
v
are very widely used as insecticides. These 
insecticidal carbamates are chosen partly for their 
selective toxicity towards, say, housefly AchE as 
opposed to mammalian AchE; this allows their use in 
domestic places without poisoning the inhabitants.
Other carbamates are used as herbicides, insect 
repellants, fungicides, anthelminthics (Brodie et 
al, 1977) and to prevent the formation of vascular 
thromboses (Girolami et al, 1977)-
substituent groups followed by conjugation (Krishna 
and Casida, 19^6; Parke, 1968; Kuhr and Dorough, 1976 
Knaak 1971).
... CHAPTER 2 
General Methods and Materials
Methyl (Koch-Light Laboratories Ltd., Bucks. U.K.) 
ethyl (BDH Ltd. Poole, U.K.) n-propyl (Kodak Ltd. 
Liverpool U.K.) and n-butyl (Eastman Ltd.) were 
obtained commercially and were reagent grade, 
apparently pure as determined by gas chromatography 
and thin layer chromatography. The remaining carbamates 
were synthesized in the Chemistry Division of the 
of the Chemical Defence Establishment and had the 
melting points shown in table 2.1. These were also 
shown to have a purity greater than 99% by the assay 
procedures mentioned above.
Radiolabelled Carbamates 
lkC-carbonyl labelled ethyl carbamate was purchased 
from Elurochem Ltd. Glossop, Derbyshire, U.K. 
specific activity 33pCi/jAmol.
iZf
C-carbonyl labelled n-propyl, n-butyl, n-pentyl,
. n-hexyl, n-octyl and n-decyl carbamates, specific 
activity about 1.3pCi/|imol, were synthesized in the 
Chemistry Division, Chemical Defence Establishment
l4
by the condensation of C-urea with the appropriate
v
n-aliphatic primary alcohol. Purity was again
at least 99% as found by thin layer chromatography 
and liquid scintillation counting of scraped sections 
of the plate; autoradiography of the tic plate showed 
that all the radioactivity was associated with the
particular carbamate.
Other chemicals and solvents
Unless otherwise stated all chemicals and solvents 
were analytical reagent grade and most of these were 
obtained from BDH Ltd. Poole, Dorset, U.K.
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A Pye series 104 gas chro:'atograph fitted with 
a flame ionisation detector was used with a lm x 4mm 
glass column packed with Porapak P (Phase Separations 
Ltd.) of mesh size 80 - 100. Gas flow rates were: 
nitrogen lOOmls/min 
hydrogen 60mls/min 
air 500mls/min 
Commonly, 2|*1 samples were applied to the column 
without any previous extraction or cleaning of the 
solution, with an S.G.E. Ltd. plunger-in-needle 
5|il syringe. The recorder response was linearly 
dependent upon the amount of carbamate placed on 
column; the concentrations of solutions of 
carbamates were determined by comparing the recorder 
peak height for the sample with a previously determined 
concentration v. response curve, which was checked 
daily. Internal standards were not used. The 
following table shows the oven temperatures and 
retention times of the various carbamates:
Carbamate Oven Temperature Retention Time
Methyl l60° C 4.0 mins
Ethyl 160 6.0
n-Propyl 180 4.5
n-Butyl 180 7*0
n-Pentyl 200 6.0
n-Hexyl 200 9«0
n-Heptyl . 220 7-5
n-Octyl 220 11.0
(iii) Thin layer chromatography
20 x 20 cm glass plates were coated with a slurry 
of silica gel G type 60 (Darmstadt, Germany) to a 
depth of 0.25mm and dried in an oven at 100 - 120°C. 
Plates were then spotted with the sample and run in 
either of the two solvent systems below, shown together 
with the R^ values of the parent carbamates:
R^ . values of carbamate in:
Carbamate
Ethyl
n-Propyl
n-Butyl
n-Pentyl
n-Hexyl
n-Octyl
Chloroform:
butan-l-ol
S L L A z _
0.62
0.68 
0.70
0.72
0.73
0.7^
Chloroform: 
ethyl acetate: 
toluene: 
methanol 
2 : 2 : 2 : 1.
0.68
0.70
0.73
0.7k
0.76
0.79
Spots were identified by spraying the plate with 
1% w/v ^-dimethylaminocinnamaldehyde dissolved in' 
equal volumes of 6M HC1 and dry ethanol. If 
radioactive, the spots were located by means of 
either autoradiography using Kodak X-ray film and 
exposing for 7 - 1 0  days before development, or by 
tic scanning on a Panax thin layer radiochromatogram 
scanner, model RTLS - 1A.
(iv) Liquid scintillation counting
A Packard Tricarb 3373 liquid scintillation 
spectrometer was used for the radioassays.
Efficiency of sample counting was determined by an 
automatic external standard using a quench curve 
established by counting known amounts of 3H or
activity in the presence of increasing amounts of 
carbon tetrachloride. Counting was usually about 
25% and 85% efficient, respectively. The 
scintillation cocktail used was made as follows:
666mls 2-ethoxyethanol 
1333mls toluene
0.53% w/v 2 ,5-diphenyloxazole (PPO, Koch-Light Ltd. 
0.05% w/v 1 ^ -di-P-C^f-methyl-^-phenyloxazolyl) 
benzene (di Me POPOP Koch-Light Ltd.)
Fry et al, 1976)
Male Porton strain albino rats weighing about 60 gms 
and allowed food and water until the time of experiment
were killed by cervical dislocation, their abdomens 
swabbed with 70% ethanol and their livers excised and 
placed in Dulbeccofs phosphate buffered saline, solution 
A, (PBS1 A'.') • The liver pieces were blotted and sliced 
into strips about 0.5 mm thick with a degreased microtome 
blade. TKese slices were washed three times for 
ten minutes each in PBS*A' (10 mls/liver) at 57°C 
in a shaking water bath and then twice' for ten minutes 
each in PBS*A* containing 0.5 mM ethylene glycol 
bis(^-aminoethyl ether)-N,N’-tetraacetic acid (EGTA).
This solution was then aspirated from the liver slices 
and replaced with lOmls Hanks buffered salt solution 
(BSS) containing 0.05% collagenase (type IV, Sigma) 
and 0.1% hyaluronidase (type II, Sigma).
After 53 - ^0 minutes incubation at 57°C the partially 
digested solution was filtered through a single layer 
of Nybolt cloth, pure size 125pm, into a beaker.
This suspension was washed four times in PBS'A’ by 
centrifugation at 50g for 60secs followed by aspiration 
of the PBS'A* and resuspension of the cell pellet in a 
further lOmls of PBS*A’. Finally the cell pellet was 
resuspended in lOmls Leibowitz L-15 culture medium 
(Flow Laboratories Ltd.) supplemented with 10% foetal 
calf serum and the suspension placed on ice until used. 
The cell yield and viability were determined by staining 
0.25mls of the (well dispersed) suspension with O.lmls 
0,h% Trypan blue solution and counting in an improved 
Neubauer counting chamber.
The viability of these preparations was 85 - 92%.
Dulbecco’s PBS*A* was prepared as follows:
137.OmM HaCl 
2.7mM KCl 
1.5mM KH^PO^
8.1niM Ra2HP0^ .12H20 
0.001$ w/v phenol red.
Hanks BSS without Ca^+ or HCO^ was prepared as follows
137.OmM NaCl 
‘ 5.AmM KC1 
0.4mM KH2P0^
0.2mM Na^PO^. 12H20
5.6mM D(.+ ) glucose 
0.001% w/v ptfenol red. 
lOmls of this solution was added to 5mgs collagenase 
and lOmgs hyaluronidase followed by 0.2mls 250mM CaGl2 
(i.e. to a final concentration of 5*0mM CaCl2) and
sufficient 2.8% w/v NaHC0_ to just turn the phenol
red pink, approximately pH7«5 (This manoeuvre was 
used to avoid the precipitation of calcium).
Chapter 3
The rapid absorption from the urinary 
bladder of a series of n-alkyl-carbamates 
A route for the recirculation of drugs.
Introduction
Previous work has shown that the urinary bladders of 
rabbits, dogs and humans are slightly permeable to 
inorganic ions such as I , Na+ , Gd , K + , H+, Br , PO*
(Head & Care, 195^* Maluf, 1953* Englund, 1956;
Hlad, Nelson & Holmes,1956; Andrysek & Schuck, 19595 
Rapoport, Nicholson & Yendt, I960). Organic molecules 
such as glycine, glucose and tryptophan and some of its 
metabolites are extensively reabsorbed from the urinary 
bladder of the mouse within 2k h of administration 
(Bryan, Morris & Brown, 1965; Morris & Bryan, 1966).
Yeates (i960) using a series of sulphonamides, found 
that there was a molecular weight limit of 200 beyond 
which these compounds were not absorbed from the bladder; 
the influence of other molecular features such as 
lipophilicity and dissociation constant on absorption 
were not considered.
Although both 5-fluorouracil and the bis-pyridinium 
oxime HS-6 are small hydrophilic molecules the former 
is not absorbed from the bladder (Bessman, Johnson 8c 
Goldin, 1975) whilst the latter is well absorbed following 
its intravesical instillation (Kepner 8c Wolthuis, 1978). 
Little or no aborption of high molecular weight compounds 
such as doxorubicin hydrochloride (Banks, Pontes, Izbicki 
& Pierce, 1977)* neomycin, polymyxin B, bacitracin 
(Chamberlain 8c Needham, 1976) cytosine arabinoside or 
adriamycin (Bessman, et al, 1975) occurs.
Borzelleca (1963 5 1965) demonstrated that nicotine 
is absorbed from rat and rabbit bladders and that 
the extent of this absorption is dependent on the 
degree of ionisation of nicotine in accordance with 
the pH-partition hypothesis.
was absorbed from the urinary bladders of humans and 
rats and the latter workers showed that the rate of
absorption of thiotepa increased as the asymmetric unit 
membrane (Vergara, Longley & Robertson, 19&9J Hicks & 
Ketterer, 1969; 1970; Warren & Hicks, 1970) became de­
differentiated after feeding the rats with the bladder 
carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide. 
Systematic studies on the influence of factors such 
as lipophilicity and molecular connectivity index on 
bladder absorption have not been described previously. 
The present studies were initiated by the realisation
from the bladder subsequent to i
kidneys. The series of aliphatic carbamates selected 
has previously been used to elucidate the absorption 
characteristics of the rat intestine; thus a direct 
comparison of the absorptive properties of the 
intestine and bladder can be made.
that urethane (ethyl (carbamate)
0.2-0.4 jiCi/ml in 0.17M  citrate - disodium hydrogen 
phosphate buffer pH 6.4 (Analar grade,BDH) with various 
solubilizing additives as shown in Tables 3.1 and 3«2 . 
Tween 80 was obtained from Hopkin & Williams,propan-1,2- 
diol (Analar grade) from BDH and the detergent Metapol 
from Durham Chemicals Distributors Ltd.
Water flux rates in the presence of various carbamate 
solutions were estimated as follows: non-radio-labelled 
carbamates were dissolved in 0.17M !citratephosphate 
buffer pH 6 . and to these were added tracer amounts of 
tritiated water ( ^H -H2O) and [^c]-polyethylene
14
glycol 4-000 ( C -PEG 4-000) (Radiochemical Centre Ltd.
3 14-Amersham) in an activity ratio, H/ G, of approximately 3* 
Female Wistar albino rats (180 to 230 g) guaranteed 
free of the nematode bladder parasite Trichosomoides 
crassicuda (Clayton & Cooper, 1970) were used.Anaesthesia 
was induced by ether and maintained with intraperitoneal 
pentobarbitone sodium, 80 mg/k^ (May & Baker Ltd.). A 
midline incision was made on the abdomen, both ureters 
were ligated with cotton and the abdomen closed with 
suture clips except for a small length over the bladder. 
The urethra was cannulated with PP25 polythene tubing 
(Portex), and the bladder was emptied by gentle pressure 
on the bladder wall. This cannula was then removed 
and replaced with another which was secured by a cotton 
ligature around the urethra.
Solutions within the bladder lumen were kept well 
stirred both by removing small amount's into the 
urethral cannula and rapidly pushing them back in again 
and by the muscular contractions of the bladder wall.
plastic scintillation vials (Sterilin Ltd.), and re­
weighed. The volume of the sample was determined .from 
the weight difference assuming the specific gravity of 
the sample to be 1.00.
Blood levels of C were determined following the 
intravesical instillation of 3 m M  P^c]-butyl carba­
mate in 20% propan-1,2-diol in 0.17M  citrate-phosphate 
buffer pH 6.4- (1 ml/kg). Blood was sampled from the 
right carotid artery and immediately centrifuged at 
2000 g for 2 min. Plasma samples (0.1 ml) were added 
to 1 ml NCS solubiliser (Amersham-Searle) in glass vials 
and counted as above, after allowing for the attenuation 
of chemiluminescence by storing the samples in the cold 
and dark for at least 3k •
The degree of binding to the bladder wall was determined 
by removing the entire bladder (approximately 73 mg) at 
the end of the 30-min absorption period and washing it 
rapidly (10 to 13 s) twice in ice-cold 0.9% w/v NaCl 
solution (saline), blotting it dry and solubilizing 
in 1 ml Soluene 100 (Packard Ltd.). The samples were 
bleached with 0.2 ml isopropanol (BDH Ltd.) and 0.1 ml 100 
volume hydrogen peroxide. Samples were counted and then 
10 jil standard [^c]-hexadecane (Radiochemical Centre Ltd') 
was added to each vial and recounted to estimate the 
counting efficiency.
To examine the possible effect of Tween 80 on the 
bladder wall a solution of 3% Tween 80 in 0.17 M 
citrate-phosphate buffer pH 6.4- (1 ml/kg) was instilled 
intravesically into each of three rats. Three control 
rats received o.l7M  citrate-phosphate buffer alone.
longitudinally with a sce^el blade. One half from 
each rat was fixed in 10% formyl saline for 6 days, 
progressively dehydrated and embedded in wax; 6 jim 
sections were cut in a microtome, floated on warm 
water and dried on slides in an oven at 37°G.
Sections were dewaxed in xylene, rehydrated in dilute 
alcohol followed by water and stained in either 
haematoxylin and eosin or periodic acid-Schiff rCagent. 
Partition coefficients were determined by Houston (1973) 
using octan-l-ol and 0.1 M  phosphate buffer pH 7*4- at 
37°C. The value for decyl carbamate was determined 
by linear extrapolation of a plot of the number of 
carbon atoms in the alkyl side chain against log 
partition coefficient for the series methyl to 
n-octyl carbamate.
The first order atom molecular connectivity indices, 
were determined according to Kier & Hall (1977)*
To examine the ability of the bladder to hydrolyse 
conjugates, ten urinary bladders from male Porton 
strain albino rats, 80 - 100 gms allowed food and 
water and libitum until the time of experiment were 
homogenised for 3 minutes in 10 mis ice cold 
0.1M Na2 HPO^ - NaH2 PO^ buffer, pH 7-4- using a, 
Silverson mixer at half speed. The homogenate was 
divided into two 4- ml aliquots and 4- - methyl 
umbelliferyl sulphate (Sigma) was added to one 
aliquot while 4 - methylumbelliferyl - p, D - 
glucuronide was added to the other, both to a final 
concentration of 200 j/M. These two substrates were 
dissolved in N,N-dimethylformaraide, the addition of
aliquot was distributed into each of 4 flasks and
these were shaken at 37°C for various times.
Following incubation, 3 nils diethyl ether were added
to each flask and shaken at room temperature for 10 mins.
2 mis of the ether phase w£c£removed to another flask
and 5 mis 0.2M glycine - NaOH buffer, pH 10,4- were
i’uvx'
added and^shaken at room temperature for 10 mins.
The ether phase was aspirated and the aqueous phase 
read in an Aminco- Bowman spectrophotofluorometer at
370 nm and A cm- 4-30nm. The fluorescence intensity 
of these samples was Compared to that of a duplicate 
pair of standards consisting of 10 tin 4-methylumbelliferone 
in 1 ml phosphate buffer extracted exactly as for, and 
simultaneously with, the samples. Linearity of 4- - 
methylumbelliferone concentration with fluorescnnce 
intensity had previously been verified. Blanks were 
run consisting of 200 piM 4- - methylumbellif eryl 
sulphate or 200j* M 4 - methylumbellif eryl - |3 , D- 
glucuronide in 1 ml phosphate buffer and incubated 
and extracted as for the sample runs.
First order rate constants for the loss of the carba­
mates from the bladder lumen were calculated by linear 
regression analysis by the method of least squares of 
a graph of:
log y = c - K t (figure 3.1)
where y = % original carbamate concentration remaining
in bladder after time, t, c = intercept on the y-axis
and K = rate of loss of carbamate from the bladder 
a
lumen*
In figure 3-2 the relationship between partition co­
efficient and rate constant for loss of carbamates from 
the bladder is shown and compared with carbamate 
absorption from the stomach (Houston, 1973) colon 
(Wood 1977) and small intestine (Houston 1973 I Wood 1977)* 
The data points and standard deviations of these earlier 
determinations have been omitted for the sake of clarity. 
Contrary to the conclusions of Hicks (1966) it has 
been found that water readily passes across the 
bladder wall in both directions* The presence of 
carbamate did not appear to affect net water flux to 
any significant extent (see Table 3»2 and Figure 3.3)•
The rates of water flux are presented as percentage 
original bladder volume (1 ml/kg) transported per
minute and were calculated as .follows: Efflux of
3 n 3[^Hj-H^O is indicated by loss of H relative to
changes in t  c] -PEG *f000, which is a non-absorbed
non-diffusible indicator, i.e.
(3H/1^ C)t=t
(^H/lZfC)t=0
3 l*f(N.B* influx of water will dilute H and C to an
solution is not affected by efflux of s o  any
change in specific activity must be due to an influx
of I^O diluting the ([^ h J-H^O.
The net volume change or flux is proportional to
1
m~m\L
( X-PEG JfOOO) t = t 
therefore the fractional volume change
t llfc] t = 0 
‘ [l4c]t=t
The %  original volume in Table 3*2 is the mean hk s.d. 
for all the values
K 1  t=0 x 100 
t=t
for each carbamate solution tested. Preliminary ex­
periments showed that for the first *f0 to 30 min water 
flux rates obey zero order rate kinetics but this
becomes a pseudo first order rate as equilibrium is
3
approached between HOH in the plasma and bladder.
The presence of 3% Tween 80 (a non-ionic surfactant; 
polyoxyethylene sorbitan mono-oleate) reduced the rate 
of loss of octyl carbamate by approximately 76% 
(P<0.001) b.ut did not affect the rate of loss of 
ethyl carbamate (Table 3»1)*
Examination of Figure 3«2 reveals that the rate of 
loss of the more hydrophilic carbamates is limited 
but that with increasing lipophilicity the rate of loss 
becomes constant.
Both k - methylumbelliferyl sulphate and ^f-methylum- 
belliferyl - p , D - glucuronide are hydrolysed by 
urinary bladder wall homogenate - the results are 
shown in Table 3»3»
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Figure 5.1
order rate of loss of three n-alkyl carbamates from the bladder lumen.
% carbamate remaining 
In the bladder lumen 
mean * S.D.
Decyl in 
5% Tween 80
Ethyl
Butyl
) 10 20 30
fime (minutes) after instillation of carbamate solution into the 
>]adder lumen.
Figure 5.2
•Relationship between absorption rate constant and partition coefficient for 
n-alkyl carbamates in the stomach, colon, small intestine and urinary bladder.
Absorption 
rate constant
mean ± S.D
0.200 -- Small intestine
0.080 -
Colon
0.040
0.020 - Bladder
0.008
Stomach
0.004 , 7000700
Partition coefficient
(The dotted line branching from the solid line for the bladder plot follows 
the absorption rate constants for octyl and decyl carbamates in the presence 
of 5% Tween 80).
Figure 5»3
Graph showing water flux rates across the urinary bladder wall under the 
influence of 5nM n-octyl carbamate in 0.1?H citrate-phosphate buffer, pH 6.4 
within the bladder lumen. 
% original volume
mean ± S.D.
120
110 ..
100
90
80
70..
60..
Influx
40
30
20
Time (minutes) afusr intravesical instillation of 5 nfvi octyl carbamate 
in 5% Tween 80 in 0.17 M citrate-phosphate buffer, pH 6.4.
Figure 5«4
Rate of appearance of ^C-butyl carbamate equivalents in the plasma.
Equivalent plasm 
concentration of 
butyl carbamate 
rtnx>i/ml; mean ±S.D.; n=5
3.0
"o
0.8
15010050
Time (minutes) after intravesical instillation of C^C)-butyl 
carbamate, 5pmol/kg.
Figure Periodic acid - Schiff reagent stained section of the
urinary bladder wall. Control - i.e. contained 0.17M citrate-phosphate 
buffer, pH 6.4, for 30minutes before fixing. Magnification 400.
Figure Periodic acid - Schiff reagent stained section of the
urinary bladder wall. Treated ~ i.e. contained 5$ Tween 80 in 0.17M 
citrate-phosphate buffer, pH 6.A, for 30minutes before fixing. Note 
the pink stained luminal edge. Magnification 400.

Table 5.1
CARBAMATE Dissolved in Concentration min”1 tj mins N c P **
% DOSE B0UN0 TO 
BLADDER WALL AFTER 30'
Ethyl citrate-
phosphate
5 mM -0.0236
±0.0078
29.4
±7.3
5 4.49
±0.12
0.7 2.414 1.29 ± 0.23
Propyl citrate-
phosphate
5 mM -0.0354
±0.0019
19.6
±1.0
4 4.44
±0.05
2.3 2.914 1.39 ± 0.74
Butyl 20% propan- 
1,2-diol in 
citrate- 
phosphate
5 mM -0.0639
±0.0014
10.8
±0.2
4 4.66
±0.12
7.1 3.414 0.64 ± 0.37
Pentyl 20% Propan 
1,2-diol in 
citrate- 
phosphate
5 mM -0.0515
±0.0063
13.4
±1.4
4 4.59
±0.08
22.5 3.914 0.23 ± 0.09
Hexyl 202 propan- 
1,2-diol in 
citrate- 
phosphate
5 mM -0.0750
±0.0126
9.2
±1.3
4 4.60
±0.04
70.8 4.414 0.76 ± 0.36
Octyl 52 Tween 80 
in citrate- 
phosphate
5 mM -0.0151
±0.0026
45.9
±6.7
4 4.51
±0.02
700 5.414 . 1.26 ± 0.20
Decyl 52 Tween 80 
in citrate- 
phosphate
5 mM -0.0086
±0.0019
80.6
±14.6
4 4.58
±0.02
7000 6.414 1.55 ± 0.27
Ethyl 202 propan- 
1,2- diol in 
citrate- 
phosphate
5 mM -0.0293
±0.0059
23.7
±4.0
3 4.55
±0.08
-
Ethyl 52 Tween 80 
in citrate- 
phosphate
5 mM -0.0324
±0.0087
21.4
±4.5
3 4.55
±0.11
Butyl citrate-
phosphate
5 mM -0.0588
±0.0052
11.8
±1.0
5 4.66 ' 
±0.08
0.73 ± 0.19
Octyl citrate-
phosphate
0. 5 mM -0.0521
±0.0142
11.2
±2.1
4 4.33
±0.07
1.23 ± 0.28
Butyl 202 propan- 
1,2- diol in 
citrate- 
phosphate
0. 5 mM -0.0698
±0.0199
9.9
±2.2
3 4.62
±0.03
Butyl 202 propan- 
1,2- diol in 
citrate- 
phosphate
50 mM -0.0626
±0.0115
11.1
±1.7
3 4.54
±0.08
Butyl 202 propan- 
1,2- diol in 
citrate- 
phosphate in 
presence of 
5CmM propyl 
carbamate
.5 tnM -0.0765
±0.0232
9.1
±2.1
4 ,4.68
±0.16
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Table 5*3
Appearance of 4-&9thyluiabelliferone at various times after the addition of 
200uM 4-methylurabelliferyl sulphate or 200jiM 4-&91 hylumbell iferyl-yS,D- 
glucuronide to an homogenate of rat urinary bladder consisting of x>ne 
bladder per millilitre. Results are expressed as means £ S.D.
Time Concentration of 4~E9tbylumbelliferone arising from activity of
1 hours
2 
5 
4
Sulphatase
11.1 £ 0.7pM 
17.0 £  2,2 
22.7 ±  3.0
29.2 £ 3.0
-Glucuronidase
7.4 + 1.4f«M
14.5 i  2.2 
23.8 ± 5 . 6
26.6 ± 1.6
The first order rate of loss of the carbamates from 
the bladder,which was preserved over a 100 fold 
difference in the concentration of butyl carbamate 
and was unaffected by the further addition of a 10 
fold molar excess of propyl carbamate, demonstrated 
that carbamate disappearance occurs by simple diffusion. 
This is also the case for carbamate loss from the 
stomach, small intestine and colon (Houston, 1973, 
Houston Upshall & Bridges 197^; 1973» Wood, Upshall 
& Bridges 1978).
Houston (1973) observed that the gastric absorption 
of octyl carbamate was reduced b y '5% Tween 80.
This concentration of Tween 80 is well in excess 
of its critical micellar concentration, and 98% of 
the octyl carbamate present was incorporated into 
the micelles under these conditions (Houston,1973). 
Houston (I973) surmised that the Tween 80 effect on 
the permeability of the gastric mucosa might be more 
significant than its influence in retarding octyl carba­
mate availability to the mucosa. The fact that 
periodic acid-Schiff reagent stained the luminal 
edge of the bladder epithelium much more intensely 
in the presence than in the absence of Tween 80 
supports this notion of a direct effect of Tween 80 
on absorptive surfaces (see figure 3*5). The increased 
staining may be due to the reaction of Tween 80 
adsorbed onto the epithelial surface with the 
periodic acid-Schiff reagent or stimulation of the 
production of mucopolysaccharides of the epithelium 
by Tween 80. Either of these possibilities would 
be expected to reduce the rate of loss of a
a hydrophilic molecule such as ethyl carbamate, as 
is the case.
It is possible to understand how a detergent may alter 
the permeability of the membrane if the detergent 
molecules are seen as being orientated so that their 
lipophilic components are located towards or embedded 
in the luminal membrane with the hydrophilic part of the 
molecule directed towards the lumen of the bladder.
4
In this way compounds would have to traverse an additional 
hydrophilic barrier in order to cross the membrane and 
so the absorption rate of lipophilic compounds may be 
retarded.
Comparison of the rates of diffusion of carbamates
across the parts of the gastrointestinal tract with
that of the bladder shows that the bladder wall is at
least as permeable as the small intestine and colon to
these straight chain carbamates and this is supported
“1 if
by the rapid appearance of C m  the plasma following
nk *1
intravesical instillation of  ^ CJ-butyl carbamate 
(Figure 3*z0*
The first order atom molecular connectivity index 
and the partition coefficients both gave very similar 
relationships with the first order rate constant.
It is clear from these results that there exists a 
considerable potential for the recirculation of both 
highly lipophilic and relatively polar drugs. Further­
more sulphate glucuronic acid drug conjugates may be hyd­
rolysed by sulphatase and ^ -glucuronidase present in the 
bladder wall (Clayson & Cooper, 1970) to less polar 
molecules which may then be reabsorbed. The
since there exists along certain lengths of the ureter 
a likely counter current exchange system.
To avoid systemic side effects following intravesical 
instillation of drugs, particularly cancer chemotherapeutic 
drugs, it seems advisable either to use the more 
hydrophilic high molecular weight agents (Editorial,
1977) or our findings would suggest the alternative 
of modifying lipophilic drugs to make them more 
hydrophilic and hence slow their absorption from the 
bladder. Ethyl carbamate (urethane), which is a car­
cinogen, is well absorbed from the bladder and it is 
likely that many other proximate and ultimate car­
cinogens also pass readily into the mucosal epithe­
lium (Kadlubar, Miller & Miller 1977) where meta­
bolism within the bladder mucosal epithelium may 
occur leading to either detoxication or intoxication 
(Uehleke, 1966; Brill, 197,7).
The bladder wall does have the capacity to hydrolyse 
conjugates, about 12 - 13% of the original substrate 
being converted over k hours in the case of both 
sulphate and glucuronide, at pH 7.k. Sulphatase 
and glucuronidase are both mainly lysozomal enzymes, 
having their optimum pH at 4 - so it is likely 
that the bladder wall has greater capacity for 
conjugate hydrolysis than shown here. However, it 
is doubtful that conjugates will be absorbed across 
the mucosal epithelium to any great extent because they 
will be ionized in the acid climate of the urine.
CHAPTER 4
The spectral interactions of n-alkyl carbamates with 
cytochrome isolated viable rat hepatocytes.
Introduction
From work done using microsomes, there appear to be three main types of 
spectral change produced by the binding of substrates to cytochrome P4 5 Q*
1 ) Type It due to the formation of a complex between the substrate and 
the apoprotein of cytochrome the affinity of this binding being
directly dependent upon the lipophilicity of the substrate (A1 - 
Gailany et al, 1978.) The formation of the complex is accompanied 
by low to high spin transition of the electrons in the 3d~* orbital
of the ferric haem iron of cytochrome P^jq (binding always involves
3+ 5the oxidized Fe state.) This means that electrons in the 3d
orbital are promoted from the sub-orbital so that they are
now distributed throughout the t~ and e sub-orbitals (Mackay
—o 8
and Mackay, 1972; Rein and Ristau, 1978; Sligar et al, 1979.)
The electronic configuration of this transition can be represented 
as folluws:-
low spin Fe^~ (s “ 1 /2 )
High spin Fe^" (s ■ 5/2)
This spin transition increases the radius of the iron atom which 
gets shifted out of the porphyrin plane, causing changes in the 
van der Waal 8  contacts between the porphyrin ring and the amino 
acid residues. On binding type I substrates the cytochrome P^q 
protein can therefore be seen to assume a specific high spin state
2g
f - 1 t  It 1 “
8
conformation (Rein and Ristau, 1978). Type 1 binding is typically
r
an endothermic reaction with high entropy changes occui^Lng on 
binding, which Indicates a hydrophobic interaction. These high
""i ,■ . .
entropy values are thought to drive the process and overcome its 
endothermic nature.
2) Type lit thought to be due to the co-ordination of the lone pair 
of electrons of nitrogen in the basic compounds which often form 
type II substrates, onto the haem iron (a ligand interaction.)
The spin transition is from high to low state in this case. Using
a series of phenyloxazoles and phenylthiazoles Smith and Wilkinson (1978) 
have shown the importance of a sterically unhindered basic nitrogen 
atom for binding - protecting the N atom in these compounds with the 
phenyl group decreased the binding affinity.
3) Reverse type Is this also seems to be due to a high to low spin 
transition of haem iron III but caused by compounds which perhaps 
do not interact directly with cytochrome P ^ q * ^ut rather increase
the aqueous solubility of cytochrome P^^-bound and membrane-associated
endogenous substrates, thereby decreasing their partition coefficient.
This would result in the partial dissociation of these endogenous
substrates from cytochrome P ^ q “ th* very reverse of what occurs
in the development of a type I spectrum (Ebel et al, 1978).
Compounds giving rise to such a spectral change are alcohols and
*
dimethylformamide.
Parry et al (1976) and Ebel et al (1978) have considered the complexity 
introduced by measuring the apparent binding affinities, K aPP, cf highly 
lipophilic substrates to lipid-membrane bound proteins. Lipophilic
compounds will tend to pool in the membrane lipids and so one may expect
to see a variation of K with the amount of lipid present. This effect
* . % . . 
does occurs Gillette (l% 3 a*b)found the Michaelig-Menten constant for
i imipramine metabolism to be a function of protein concentration in his
microsomal system; Waterman et al (1973) found K for the interaction
of cyclohexane with microsomal cytochrome P^g to vary with protein
concentration. For a substrate approaching a lipid enclosed binding
site, K ®pp 4  oo is K -) 0 . Also K app -» k* fz] . Ktrue as K — > 0 0. "8 r p , S u O 8 p
where:
Kp is the membrane lipid/aqueous partition coefficient; (e^  is the total
receptor concentration^* is the receptor density coefficient.
r is the ratio of the volumes of the lipid to the aqueous compartments.
Rtrue _ R app
(Parry et al, 1976)
In microsomes without added exogenous substrates Ebel et al (1978),
Waterman et al (1973) and Cinti et al (1979) have shown that at 
temperatures of 20 - 36°C, about 40% of the cytochrome P^g *s 
present in the high spin state. Ebel et al (1978) and Waterman et al (1973) 
consider that 28% - 35% of the cytochrome P^g Is available for low to 
high spin transition. Moldeus et al (1973) provided . evidence that 
cytochrome P ^ q is mainly in the oxidized non-substrate bound form in a 
suspension of isolated rat hepatocytes.
von Bahr et al (1974) found that the binding of hexobarbitone to 
cytochrome P^g *n isolated viable hepatocytes does not require energy: 
hexobarbitone reached the binding site by simple diffusion. The
rate of binding was dependent upon temperature and the concentration 
of hexobarbitone. Maximum binding occurred within one second of the 
addition of hexobarbitone. Using three other barbiturates with a 
very narrow range of oil/water partition coefficient (1.84 - 7.62) they 
also showed the rate of appearance of the (type 1 ) spectral change to 
be proportional to the partition coefficient. There was no correlation 
between partition coefficient and binding constant, K •
The objective of this study was to confirm that n-alkyl carbamates 
bind to cytochrome P^q *n isolated viable rat hepatocytes with the 
formation of a type 1  spectral change; to measure the dissociation 
constant,K , for each carbamate in this interaction and to compare this 
value with that obtained for the interaction of the same carbamates with 
cytochrome P^ «jq in hepatic microsomes. Also the relationship between 
affinity of binding,1 /K , and partition coefficient, rate of formation 
of the spectral change and any changes in the spectrum once established 
were to be studied.
Method
Male Wistar albino rats weighing about 50gms and allowed food and 
water ad libitum were pretreated with sodium phenobarbitone,80mg/kg 
daily for 3 days,by intraperitoneal injection.
Hepatocytes were isolated as described in Materials and Methods with 
the difference that the cells were washed and resuspended in Dulbecco* 
phosphate buffered saline, PBSA, without phenol red but supplemented 
with lOOmg % D-glucose (ie. 5.56 mM).
A Varlan Cary 219 spectrophotometer was used to record the difference
spectra. Each cuvette contained 2.5ml of a suspension containing
6
(final concentrations) 2 x 10 hepatocytes/ml and 2.5% w/v gelatin
(powder; BDH Ltd.) in PBSA containing lOOmg % D-glucose. Cuvettes
owere thermostatted to 37 C.
\
n-Alkyl carbamates were dissolved in N,N-dimethylformamide (BDH Ltd.) 
at a concentration such that the addition of Ipl of this solution to 
2.5ml cell suspension produced a concentration equal to that of the 
dissociation constant, K£, of each carbamate determined by Al-Gailany
et al (1978) for the interaction of these carbamates with cytochrome
*
P.__ in rat liver microsomes.
Results
Spectral changes,figure 4*1,were measured from the peak to trough of
the type I spectra, ie. AA^Qn_A7nntB, and a Lineweaver-Burke plot
made of substrate concentration, 0 . versus spectral change, from
which the dissociation constant, K , and maximum spectral change,8
AA , were determined;max
1 1 Ks 1
Aa fsT Aa  Aaw  •* max max
One such plot is shown in figure 4.2 for n-pentyl carbamate.
The viability of the hepatocytes was maintained at 80-85% throughout 
each experiment.
The affinity of binding, ie. 1/K , is linearly related to partition
-S
coefficient from n-butyl to n-octyl carbamate but n-decyl carbamate 
appears to have a lower than expected affinity, figure 4.3, The 
partition coefficients were determined by Houston (1973) in 0*1M 
phosphate buffer - octan-l-ol at 37°C.
Figure 4.4 shows the relation between microsomal K and K in hepatocytes.s s
Table 4.1 summarizes these results.
Figure 4*1
Type I difference spectrum obtained on addition of various 
concentrations of n-heptyl carbamate to a suspension of
rat hepatocytes.
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Pi.gure 4.2
Graph showing a Lineweaver-Burk plot to determine the dissociation constant 
and maximum spectral change for the interaction of compounds with 
cytochrome ?450, illnstriated here for the case of n-pentyl carbamate.
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The equivalent constants for the interaction of the same carbamates in hepatic
raicrosomes are as follows:
70 = 5,841pM; m = -0.613; n = 6- correlation coefficient = -0.9862.
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Graph showing the relation between the dissociation constants of 
n-alkyl carbamates interacting with cytochrome ?450 in hepatic microsomes 
and isolated viable hepatocytes, both isolated from male Wistar albino rats. 
Equation of the straight line*
lo&e 7 c loSe yQ * x*
y0» 0.05CUM; m — 1,55; : n s 5; correlation coefficient s 0.9970.
Table 4.1
Eepatocyte Ks 
as a fraction Absolute 
Partition Microsomal of microsomal hepatocyte 
Carbamate, coefficient. Ks. pH. Kg. Ks. pM.
n-butyl 7 1900 0.80 £ O.94. 1520 +
1786
■ ' 1
n-pentyl 25 950 0.47 ± 0.15. 457 +
140.
n-hexyl 70 500 0.44 ± 0.26. 220 £
150.
n-heptyl 250 I70 0.26 + 0.15. 44.2 +
22.1.
n-octyl 700 71 0.25 £ 0.14. 17.8 +
9.9.
n-decyl 7000 55 0.71 + 0.25. 24.8 +
8.8.
AAmax.
590 - 420 nm.
0.052 + 
0.008.
0.041 £ 
0.008.
0.041 ± 
0.012.
0.054 ± 
0.028.
0.052 + 
0.007.
0.046 £ 
0.010.
Binding characteristics of the type I interaction of n-alkyl carbamates with 
cytochrome P450 in hepatocytes isolated from phenobarbitone treated rats. 
(Microsomal data from Al-Gailany et al, 1978).
Discussion
Type I binding was found in all cases for these carbamates in
-I'v .
hepatocytes, as oecu^ fed in microsomes (Al-Gailany et al, 1978).
The binding constants determined in hepatocytes are within an order 
of magnitude (ie. 0.1 - 1.0) of those found in raicrosomes. The 
higher than expected K for n-decyl carbamate may be due perhaps 
to its being bound by membrane lipids before gaining access to the 
site of the cytochrome protein. It should be noted that the
maximum aqueous solubility of n-decyl carbamate is 10.5pM, calculated 
from the linear regression correlation between the number of carbon 
atoms in the n-alkyl side chain and the logarithm of the aqueous 
solubility (Houston, 1973). In all cases the spectra developed 
within one second of the addition of substrate. It can be concluded 
from this that access to cytochrome does not limit the rate of
metabolism of these compounds, at least by isolated hepatocytes.
No changes in the developed spectrum were seen when it was scanned 
repetitively under either aerobic or anaerobic conditions for up to 
20 minutes after the addition of substrate (in this case lOOpM 
n-octyl carbamate). This result differs from that of Moldeus et al (1973), 
von Bahr et al (1974) and Sweatman (1980) who found such changes within 
90 - 120 seconds. Under aerobic conditions these changes are thought 
to be associated with the metabolism of the bound substrate. Metabolites 
of n-octyl carbamate are certainly present within 20 minutes. Under 
anaerobic conditions the spectral changes with time seem to be due to
a change in the oxidation state of the haem iron III of cytochrome P4 5 Q “
2+substrates are bound to this form and so any reduction to the Fe 
state should decrease the magnitude of the type I spectral change.
Also, interference arising from changes in the oxidation/reduction 
state of mitochondrial cytochromes may be expected.
The formation of a binding spectrum upon addition of exogenous substrate 
requires an explanation of how the binding site of at least a 
proportion of the cytochrome P^q molecules present remains free of 
endogenous substrate (eg. lipids, cholesterol and fatty acids) for 
such binding to occur. It is possible that this is due to the 
presence of various molecular forms of cytochrome P4 5 Q* each 
having different affinities for various classes of substrates.
Perhaps a particular form of P ^ q exists exclusively for exogenous 
substrates. Alternatively, most of the endogenous substrates may 
be expected to form part of the membrane of the endoplasmic reticulum, 
and depending upon how well bound the components of this membrane are 
then they may not be available for binding to cytochrome P^^q even 
though they must be very closely associated with it.
Finally, the presence of a stable binding spectrum may be indicative 
of a rate limiting step occurring in the cyclic mechanism of 
cytochrome P ^ q et the level of the reduction of iron III - 
cytochrome P ^ q (to which form substrate binding occurs, giving rise 
to a binding spectrum - see next chapter) to iron II - cytochrome P ^ q *
CHAPTER 5
Metabolism of n-alkyl carbamates by isolated rat 
hepatocytes, and in the rat in vivo.
Introduction
The metabolic conversions undergone by drugs and the mechanisms by 
which these occur have been reviewed and catalogued many times - 
Parke (1968), Testa and Jenner (1976a) and Jenner + Testa (1978)*
It is the intention of this introduction to discuss only those 
aspects relevant to the n-alkyl carbamates.
Metabolism proceeds following the.binding of the substrate to 
cytochrome P ^ q * This protein is the last link in an electron 
transport chain contained in the membrane of the endoplasmic 
reticulum. The overall reaction describing substrate oxidation 
is as follows:
R -  H + NADPH + H+ + 02  R - OH + NADP+ + H20
Cytochrome P^jq receives one electron via cytochrome P ^ q r reductase
3+ 2+(ultimately from KADPH) which reduces the haem iron from Fe to Fe 
(Peterson et al, 1977; Cooper et al, 1977).
Oxygen can then be bound by the haem iron II and is subsequently 
activated by reduction by the second electron (Fry and Bridges, 1977):
ISO f“€ 3+ (Gives rise to 
| binding spectrum).
€
J
P|t-io' Fea +
a
f.H o.
The oxygenating species may be a highly electrophilic oxenoid structure:
;
quantum mechanical calculations of the electron densities of C - H bonds 
of substrates known to be hydroxylated by the cytochrome system have
shown that those bonds with the highest electron densities are 
preferentially oxidized, eg. H bonds in alkyl groups attached to
oxygen, nitrogen or sulphur atoms or 7t-bonded systems (aromatic rings; 
carbon-carbon double bonds; carbonyl groups), (Testa et al, 1978;
Testa and Mihailova, 1978).
The (co-.l) position appears to be favoured in the hydroxylation of 
n-alkanes having up to 7 - 9 carbon atoms, but above this length
Cd - oxidation seems to be preferred (Testa and Jenner, 1976 b). Thus 
n-heptane is metabolised mainly to n-heptan-2 -ol 
(Frommer et al, 1972) while n-decane 
(Ichiharaetal, 1969) and n-hexadecane
(Knsunose et al, 1969) are u-oxidized to the primary alcohol and 
then further oxidizedto the corresponding acid. Frommer et al (1974) 
have suggested that the specificity in the position of hydroxylation 
can be accounted for by the numerous substrates having different 
affinities for the various forms of cytochrome which exist 
(Guengerich, 1978).
For alkyl side chains on highly substituted carbon atoms (to- 1) 
hydroxylation seems to be preferred for straight chains containing 
four or more carbon atoms while n-propyl chains are hydroxylated 
mainly at the o-position (Gilbert et al, 1975<x*i>;Testa and Jenner, 1976 b). 
Grove et al (1974) demonstrated the 1) hydroxylation of
butobarbitone and its subsequent conversion to 3*-ketobutobarbitone.
The object of this study was to determine whether these n-alkyl 
carbamates are metabolized by hepatocytes and if so how such 
metabolism depends on lipophilicity. Also to attempt to identify 
any metabolites and determine any variation in type of metabolism 
with lipophilicity or n-alkyl chain length.
Methods
Hepatocytes were Isolated as described in Materials and Methods* 
(P^cJ-carbamates were incubated with’ 2  x 1 0 ^ cells/ml in a 
concentration of 0.5mM (about 1.5jiCi/pmol) in an incubation volume 
of 1ml. The presence of metabolites was demonstrated by tll.c. 
followed by autoradiography. The amounts of each metabolite 
produced were measured by scraping radioactive spots off t.l.c. 
plates and counting radioactivity in a liquid scintillation 
spectrometer. Metabolites were recovered quantitatively,
70 - 80% of the activity applied to the plate being accounted for.
Preliminary identification of metabolites was carried out using
H u l
n-hexyl L QJ-carbamate as a representative of the series.
[l4 *1
700mM n-hexyl I Cjcarbamate dissolved in polyethylene glycol 300 
was administered intraperitoneally to six 300gm male Porton strain 
albino rats, allowed food + water ad libitum, in a dose of 0.7mmol/kg. 
After 3 hours the rats were anaesthetised with diethyl ether, the 
abdominal aorta was exposed and the rat exsanguinated from this site 
into a syringe containing 0.5ml 0.9% w/v saline with 200 I.U. heparin/ml. 
The blood was immediately centrifuged for 10 mins at 2000g and 4°C.
The plasma was separated (approximately 30mls from six 300gm rats) 
and shaken four times with two volumes diethyl ether at room 
temperature, for two minutes each time. The pooled ether extracts 
were dried with anhydrous sodium sulphate and evaporated by rotary 
evaporation at 20°C and 260mmHg.
The residue was redissolved in ether and applied to a t.I.e. plate 
and run in chloroform: butan-l-ol, 9 : 1 .  values are shown in 
table 5.1. Radio active spots were identified by radiochromatogram 
scanning, then scraped off and re-run in ethyl acetate: methanol, 7 : 3 
Radioactive spots were again scraped off the plates, extracted with 
ether and put in clean glass tubes (solvent washed and heated to 350°C) 
The ether was evaporated under a stream of nitrogen and the samples 
were then stored dessicated under nitrogen at -20°C to await analysis 
by mass spectroscopy.
The use of chemical ionization was chosen to provide parent ion 
peaks,and therefore the molecular weights of the metabolites,and a 
limited fragmentation pattern. Mass spectra were recorded on a model 
V. G. Micromass 7070F mass spectrometer using isobutane as the ionizing 
gas. The following settings were used:
Inlet mode : solid probe
Inlet temperature : 50 - 60°C
Source temperature : 200°C
-4Source pressure : 10 Torr
Ionization voltage : 70 eV
Acceleration voltage : 4 , 0 0 0  V
Results
Figure 5.1 and 5.2 show that the n-alkyl carbamates are metabolized 
by isolated hepatocytes, the extent of this metabolism depending 
upon the lipophilicity of the particular homologue.
The second metabolite, ie. that with the highest Rp value, Rp in 
table 5. I , to be produced (in the case of n-pentyl, n-hexyl and 
n-octyl carbamates) appears to be less polar than the first, ie. R^, 
being more mobile in this hydrophobic solvent system than the first 
metabolite. It is therefore unlikely to be a sulphate or glucuronic 
acid conjugate.
The amounts of each metabolite produced after 1 hour incubation can 
be seen in figure 5.2. . Figure 5.!0)and 5.3 show, the rate at
which each metabolite appears, using n-hexyl carbamate as a 
representative of the series. These results are summarized in 
tables 5,2 and 5.3. Thin layer chromatography of the cells 
ruptured by osmotic lysis and sonication following incubation with 
the carbamates did not show any spots not accounted for by known 
metabolites or parent compound. It was therefore concluded that 
formation of reactive metabolites and covalent binding to cell 
constituents did not occur.
The results of the mass spectral analysis using a chemical 
ionization probe can be seen in figure 5.4. Parent molecule ion 
peaks at m/e 162 and 160 indicate that the metabolites may be a 
hydroxy-alkyl and ketone, respectively. The fragments at m/e 43 
in both metabolite spectra are probably due to CH^CO , which suggests 
(cj — 1) oxidation. Those at m/e 101 (hydroxy) and m/e 99 (ketone) 
are probably due to the breaking of the molecule at the ester link 
to give CH^CH.OH. (CH^)* and CH^CO. (CH^)^ respectively, while m/e 144 
for the alcohol probably arises by loss of H^O from the parent molecule.
Figure 5. • (a): Autoradiogram of n-alkyl carbamates and their metabolites, 
after incubation of parent carbamates with rat hepatocytes for one hour.
Figure 5*1 (D)i -Autoradiogram of n-hexyl carbamate and its metabolites 
at various times after incubation with rat hepatocytes.
*>«*•>* r ™. f ----- —  —---------------------    •----
dUjoro^ or-*. 
__ '\otuJL*~e.
“  X:±.l.l
> fJ
C.t Pr £of Pc*t HCy. O tf"
lotvCf*
[co*t
If, 7 Me^ obU^ v SL/T ««^r.»©o<£ T«-**-veS «UM“uM O^u^ J^ Xc^ v
' dj- &.l*-tj£ e^ jc(r(^ .^o^ € itfe^A/fecy^'eS .
c M o r o ^ o  r  *vv : 4:1  / V \  » T
Oci^ U.—«
5' /O' io' 40' to'
110-
100-
90-
Metabolite 
concentration found 
in medium after 
incubation, jiM. 80
70-
60-
50-
40-
50-
20-
10
0.7
— I
7007 70
Partition coefficient
&  Total metabolites
X---x Ketone metabolites
«---& Hydrosgr metabolites
Figure 5. y.
Relationship between partition coefficient and amounts of metabolites produced 
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Mass spectra, of n-hexyl carbamate and its two major metabolites isolated from 
plasma, arranged in order of their mobility on thin-layer chromatography. 
These spectra were recorded using a chemical ionization probe.
Table 5• 1
values of n-alkyl carbamates and their major metabolites in two solvent systems.
Carbamate
Ethyl
n-Propyl 
n-Propyl*
n-Butyl 
n-Butyl*
n-Pentyl 
n-Pentyl1 * 
n-Pentyl*
n-Hexyl 
n-Hexyl11 
n-Kexyl *
n-Octyl 
n-Octyl»1 
n-Octyl'
Chloroforms
butan-l-ol,
9-1
0.62
0.68
0.11
0.70
0.17
0.71
0.49
0.19
0.72
0.57
0.25
0.74
O.69
0.40
Chloroform? 
toluene? 
ethyl acetate? 
methanol, 
2?2?2:1
O.67
0.70
0.41
0.72
0.46
0.75
0.54
0.46
0.76
0.58
0.47
0.79
O.67
0.55
The values are arranged such that Rf(parent) >Rf(ketone) >Rf(hydroxy)
Table 5.1
Concentration of metabolites of n-alkyl carbamates in the cell suspension 
medium after incubation with rat hepatocytes for one hour. Results are 
expressed as means + S.D. of four experiments.
Carbamate Metabolite concentration, uH. Ratio? [ketone]
Ketone Hydroxy Total (hydroxyj
Ethyl 0 0 0
n-Propyl 0 17.5 £ 6.5 17.5 £ 6.3
n-Butyl 0 41.3 £ 13*8 . 41.5 £ I3.8
n-Pentyl o 47*4 + 15.9 47*4 ± 15*9
n~Hexyl 28.1 £ 10.4 66.3 + 23*7 94-4 ± 50.6 0.42 £ 0.19
n-Octyl 63.5_+ 26.4 62.6 £ I9.0 126.1 £ 45.8 1.01 £  0.48
Table 5*3
Concentration of metabolites of n-hexyl carbamate in the cell suspension 
medium after incubation with rat hepatocytes for various times. Results 
are expressed as means £ S.P. of four experiments.
Time Metabolite
Ketone
concentration, jiM. 
Hydroxy Total
Ratio» [ketone|
(Wdrojy]
5 minutes 2.0 +0.7 5.1 £ 1.2 7.1 ±  2.4 0.39 ± 0.15
10 5.1 £ 0.9 12.3 £ 4.8 15.4 £ 6.8 0.25 £ 0.11
20 5.2 £ 3.0 20.3 £ 6.9 25.5+13.8 0.26 £ 0.15
50 8.4 ± 5.7 29.1 £ 9.7 37.5 £ 19.0 0.29 £ 0.13
40 10.6 £ 5.3 45.8 £15.5 56.4 ± 23.2 0.23 £ 0.18
60 18.1 £ 7.8 53.2 £ 23.8 71.3 ± 35.6 0.34 £ 0.21
Discussion
The extent of metabolism is found to be dependent upon the lipophlliclty 
of the parent carbamate. On the evidence of their thin layer 
chromatographic mobilities, the in vivo and in vitro metabolites of 
n-hexyl carbamate appear to be the same. Also, on the same evidence, 
the metabolite pattern appears to be the same throughout the series 
(figure 5.1(a)). It should be emphasized that hydrolytic cleavage 
of the carbamate bond represents the major metabolic pathway for- 
the carbamates up to and including n-hexyl (see next chapter).
The hydroxylation of the alkyl side chain is likely to be due to 
cytochrome hy analogy with fatty acid and barbiturate side
chain oxidation. Both the extent of metabolism and affinity of 
substrate binding to cytochrome are well correlated
with lipophlliclty. Further oxidation to the ketone is possibly 
due to dehydrogenases or oxygenases in the cytosol or mitochondria. 
Tissue fractionation studies would show whether this is so.
The ratio of [ketone^ metabolites in the medium can be seen to increase 
[hydroxy]
on ascending the series but to remain relatively constant with time 
for a particular homologue.
An often quoted reason for metabolism of drugs is that this makes them 
more hydrophilic and therefore easier to excrete. However, in the case 
of the carbamates, the derivatives are not much more hydrophilic,and 
the second metabolite, le. ketone, which is presumably derived from the 
first, is even more hydrophobic. An analogy with the (cj - 1) oxidation
of alkyl chains is the |3-oxidation of fatty acids. In the brain,
mitochondria can cc-hydroxylate fatty acids and then further oxidation
to ot-keto acids occurs* followed by oxidative decarboxylation, the
latter two conversions taking place In the endoplasmic reticulum and 
2+
requiring 0^, Fe and ascorbate. Hepatic cytochrome catalyzes
the Q-hydroxylation of some medium to long chain fatty acids which
can then be further oxidized to oc,w-dicarboxylic acids (White et al, 1978).
It Is not yet possible to explain why hydroxylation occurs specifically 
at the (o - 1 ) position since the alkyl part of the molecule is quite 
bland as regards variations in electron charge density. Perhaps it is 
due to a polarisation of the substrate molecule while it is bound to 
the active site of the cytochrome enzyme.
CHAPTER 5 t APPENDIX
Introduction
The electron ionization mass spectra and proton nuclear magnetic 
resonance spectra were obtained for most of the n-alkyl carbamates 
and approximate molecular orbital calculations using the method of 
complete neglect of differential overlap/spectroscopy (CNDO/S)(del 
Bene and Jaffe, 1968) were performed.
This was done in preparation for a more detailed study of their 
metabolism which was not completed. They are included in this 
appendix because some interesting trends and correlations were noted.
Methods
Mass spectra of the parent n-alkyl carbamates were recorded on an 
AEI MS12:mass spectrometer using electron ionization, with the 
following settings:
Inlet mode : Direct
Inlet temperature t 15 - 70°C
Source temperature i 100 - 180°C
Source pressure s 8  x 10~^ Torr
Ionization voltage i 70 eV
Acceleration voltage s 8,000 ¥
Scan mode 3 Magnetic
Proton nuclear magnetic resonance spectra of the parent n-alkyl 
carbamates were recorded in a Bruker WH-90 NMR spectrometer. The 
samples were dissolved in deuterated chloroform, CDCl^, using 
tetramethylsilane as an internal standard. The magnetic field 
strength was adjusted to bring the tetramethylsilane to resonance 
at a frequency of 90.0229 MHz and 25°C. Pulsed Fourier transform 
spectra were then recorded with a pulse width of 2 |isec and 
100 - 500 scans.
Bond orders and electron densities were calculated by the CNDO/S 
method of Del Bene and Jaffe (1968), using programme number QCPE 174 
on the Manchester University computer, having set the molecules in 
their standard geometrical conformations.
Results
The major peak in the electron ionization mass spectra occurs at 
m/e 62 (except for methyl and ethyl carbamates) - figure 5mi* 
This is thought to arise from the following MacLafferty 
re-arrangement: -
H e ' * * *
-> /v/H^CooK + C H 2
s Carbamic acid
/£ (M.W.= 61)
Carbamate
Other mass peaks may be due to the following fragments: 
m/e 29 J CH3 CH,+
m/e 31 » CH 0+ or CH, - 0H+ or C^MH,
+
m/e 44 t 0 - C « NH2  or C02  or C ^ N  or C ^ O
+ +
m/e 45 r CH^H « OH or CH3 CH2 0 T or CH3 CH2 NH2
The presence of the hydrocarbon side chain gives rise to an ion
+ +
series, so ion peaks may be expected at m/e 29 (C2 H3); 43 (C3 H^);
j.
57 (C^Hg) etc. This can be seen particularly well in the case of 
n-decyl carbamate.
High resolution mass spectroscopy using carbon dioxide and argon
as internal standards showed that the mass peak at m/e 44 is due
+
to the fragment 0 » C » HH^.
The relationship between n-alkyl chain length and m/e 44 peak height is 
shown in figure 5.6.
The precise molecular weights of the various possible fragments 
are as follows:
Fragment m/e
C0 2  43.9898
O.C.NH2  44.0136
C-H.O 44.02622 4
C2 H6N 44.0499
The proton nuclear magnetic resonance spectra show an AfiX pattern 
for the carbamates - two examples are shown in figure 5.7. Complete 
lists of peaks and chemical shifts are given in table 5.4 • The 
peaks have been assigned as follows:
Srn2 >  k j i 2 >  Sy % . f 2 >  *cuh3
where $ is the chemical shift in parts per million (p.p.m.). The
characteristically broad band of the amide protons is due to their
14being exchanged during quadrupole relaxation of the x-K. The 
inductive effect of the highly electrophilic carbamate group mayr 
explain the downfield (paramagnetic) shift of the protons but the 
magnetic anisotropy of the carbonyl bond may also play some part.
The splitting of the peaks of the alkyl chain protons is due to 
spin-spin coupling - eg. in the case of n-propyl carbamate 
(figure 5.7 (a)) the Cp protons will be split by coupling with 
the C,*-protons, giving rise to a triplet which can be further 
split by the protons to produce a multiplicity of twelve lines.
Since the coupling constant is approximately equal to
there is extensive overlapping and a sextet appears centred on 
1.67ppm, the relative intensities of the resonances being 
1 s 5 : 10 : 10 s 5 : 1. Some distortion has occurred because 
and are not exactly equal. As the series is ascended 
complete overlapping of these lines occurs - eg. n-hexyl 
carbamate, figure 5.7(b).
The CHDO/S calculations confirm the highly electronegative 
nature of the carbamate moiety. Shown in table 5.5 are the 
sigma and pi bond orders between the non-proton atoms:
, - P^ + P*.total cr
The electronic charge, Q, on each atom is also given - these can 
be thought of as the number of outer shell electrons per atom. 
The results for n-pentyl carbamate must be regarded with some 
suspicion since they are inconsistent with the results for the 
other carbamates.
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Carbamate Atom P<r P7i ptotal ^total average)
n-Propyl IT
Cfcarbonyl) 0.9412 
o(carbonyl) 0.9537 
Ofester) 0.9513 
C(l alkyl) 0.9444 
Cl2 alkyl) 0.9538 
C(3 alkyl) 0.9553
n-Butyl H
C( carbonyl) 0.9412 
Of carbonyl) 0.9537 
0(ester) 0.9513
Cfl alkyl) 0.9443 
C(2 alkyl) 0.9532 
Cf3 alkyl) 0.9547 
C(4 alkyl) 0.9540
n-Pentyl IT
Cfcarbonyl) 0.9423 
Of carbonyl; 0.9534 
Of ester) 0.9500 
Cfl alkyl) 0.9497 
Cf2 alkyl) 0.9521 
Cf3 alkyl)
C U  alkyl) 0.9134 
C(5 alkyl) 0.8913
n-Hexyl IT
Cf carbonyl) 0.9412 
0(carbonyl; 0.9537 
Oiester) 0.9513 
Cfl alkyl) 0.9443 
C(2 alkyl) 0.9532 
Cl 3 alkyl) 0.9542 
C(4 alkyl) 0.9530 
C(5 alkyl) 0.9533 
C(6 alkyl; 0.9538
5.1820
0.4598 1.4010 3.5987
0.9815 1.9352 6.4239
0.4143 1.3656 6.1749
0.1447 I.O891 3.9229
0.1413 1.0951 4.OI65
0.1529 1.108a 4.0397
5.1821
0.4598 1.4010 3.5987
0.9815 1.9552 6.4239
0.4144 1.3657 6.1751
0.1448 I.O891 3.9248
0.1413 1.0945 4.0172
0.1471 1.1018 4.0166
0.1523 1.1063 4.0402
O.4686 I.4IO9 -
0.9850 1.9584 -
0.3987 1.3487 -
0.1474 1.0971 -
0.1392 1.0913 -
0.1334 1.0468
0.1938 1.0851 —
5.1821
0.4597 I.4009 3.5987
0.9815 1.9352 6.4240
0.4145 1.3658 6.1752
0.1447 I.O890 3.9251
0.1413 1.0945 4.OI92
0.1472 1.1014 4.0192
0.1464 1.0994 4.0179
0.1464 1.0997 4.0175
0.1523 1.1061 4.0410
0.8869
O.967O
0.9868
O.9867
0.8870
O.9676
0.9863
0.9880
0.9879
0.8870
0.9677
O.9869
0.9879
0.9887
0.9891
0.9885
Table 5.^
Some electronic parameters for four n-alkyl carbamates. See text for explanation.
Discussion
The relationship between the number of carbon atoms in the n-alkyl 
chain and the negative logarithm of the relative intensity of mass 
peak at m/e 44 (figure 5.G) is thought to have the following 
explanation. As the series of carbamates is ascended the inductive 
effect of the alkyl group increases, so building up charge on the 
ester bonds
BH0 -2 j,*,
0
Electronic charge is thought to build up preferentially on this
bond under the influence of the carbonyl oxygen atom. In
consequence, this bond becomes more difficult to break and the 
+
fragment 0 « C « NH^ becomes more scarce as the length of the 
alkyl chain increases. Although this explanation is not borne 
out by the P^ , and estimates for this bond by the
CNDO/S calculations, it is quite possible that this method of 
approximate molecular orbital calculation A is not sufficiently 
sensitive to detect such small changes in bond orders and 
electron densities (Pople and Beveridge, 1970).
A reasonable agreement between the charge on the protons, 
^H(average)’ calculated by the CNDO/S method and the chemical 
shift of those protons in the nuclear magnetic resonance spectra 
in accordance with the relationship S K “Qjj was found. Thus 
the amide protons, having a low charge, are subject to a large 
downfield shift, while the protons have chemical shifts 
Intermediate in value between the amide and the protons.
CHAPTER 6
An analysis of the pharmacokinetic data for ethyl, 
n-butyl, n-hexyl and n-octyl carbamates.
Introduction
Wood (1977) studied the pharmacolcinetics of four n-alkyl carbamates 
using male Wistar albino rats and injecting them intravenously with 
a standard dose of 5jimol/kg of one of the four carbonyl - C - 
carbamates - ethyl, n-butyl, n-hexyl or n-octyl. Plasma levels 
of the parent compounds and total radiolabelled metabolites were
14
followed for three hours. Also the excretion of CO^ for 24 hours
was measured.after the identical treatment of further rats. In the
present work the plasma levels of ethyl carbamate obtained by Wood have
been confirmed over a 3000-fold dose range using both radioassa^ of 
14C-ethyl carbamate and, for the higher doses studied, the gas 
chromatographic assajr for ethyl carbamate.
The plasma concentration versus time curves were fitted by the
bi-exponential model for drug distribution and elimination for all
four carbamates. However, it was noticed for ethyl carbamate that
this model does not account for the variation of total amount of
parent compound in the body with time. This observation has since
been extended to the other three carbamates, where it can betseen
14in Woods data that total plasma C activity (ie. parent carbamate 
plus metabolites) remains constant with time. It is particularly 
striking in the case of ethyl carbamate where the plasma level remains 
virtually constant after the initial distribution phase, despite the
14
rapid loss of ethyl carbamate as CO^ (figures 6.1 and 6.2). Ho 
plasma metabolites of ethyl carbamate were detected.
wherei
, is the pseudo-equilibrium volume of distribution.
C* is the plasma concentration at time, t.
D is the dose ** 5pmol/kg.
m is the fraction of the dose metabolised by all routes at time.
Some characteristics of the pharmacokinetic data have since been 
realized which lead to a model which explains the above paradox.
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Carbamate hom ologuet
Constant Ethyl n-Butyl n-Hexyl n-Octyl
0.892 0.642 0.522 0.330
1 - P. 0.108 0.358 0.478 0.670
hag t*™)- 1.01 0.75 0.35 0.25
*88 (hrs)‘ 3.66 3-00 2.75 3.50
Rategg (jimol/kg/hr). 1.22 1.07 0.95 0.47
A(pM). 8.5 4.2 4.4 5.6
~B (pH). 6.6 1.5 1.7 2.8
06 (hr"1). -15.06 -5.76 -10.38 -18.48
|S -0.036 -0.72 -0.60 -2.88
tj^hrs). 19-25 0.96 1 .16 0.24
:*12 (te">- 8.40 2.46 5.58 6.78
■'*21'(to*-1).' 6.6 2.04 3-54 8.1
kel (hr"1)" 0.078 2.04 1.92 6.6
Tdss Ks/kg). 227 ' 583 650 327
Vdp (“is/kg). 228 748 755 403
i^cc XjjM.hr). 184 2.8 3-3 1.3
2 - 1  values?
m (hr ”'). -O.372O -0.5121 -0.4539 -0.4353
m* (hr“r). -0.2159 - '■
4J£ (to8). 1.86 1.55 1-53 1.59
- - 3.21 -
r (a) -0.9947 (10) -0.9986 (9) -0.9986 (7) -0.9947
r' (n*) - - -0.9952 (5) -
c (pmol/kg). 6.37 5.05 3.06 2.0
c* (paol/kg) . \ - - 1.30 -
Discussion
Figure 6.2 can be split into three distinct regions: a lag time
a steady state rate of CO. excretion, Rate occuring during t ,
- - -dm 88  88
and a further non-linear region of CO. appearance. Rate .t ** FD;
* as ss
where F is the fraction of the dose excreted as CO^ at t“ oo.
A, B, cL and £ are the standard constants in the biexponential 
description of the plasma levels of the parent compound:
Ct » A + Be~'^ t 
P
is the half life of elimination; is the volume of
distribution during the steady state of distribution
? of parent compound between the central
and tissue compartments; AUC is the total area under the plasma 
concentration versus time curve for the parent compound. These 
values are listed in table 6.1.
The scheme proposed here to explain .C^ 4 D(1 - m) is that
14the production and excretion of CO^ from the carbamates takes 
place in some tissue compartment such that any changes which occur 
in the levels of carbamate here do so completely independently of 
any changes in the central compartment and are not reflected by 
changes in the central compartment (plasma) concentration of carbamate:
Injection
Tissue 
compartment
y
Excretion of CO^ occurs
following hydrolysis of 
carbamate.
Considering the body as whole, the amount of drug remaining varies with
i
time as the sum of these two independent processes:
cp*vdfi
where f is the amount (jimol/kg) of the dose excreted as CO^ *t time, t.
The central compartment gives rise virtually exclusively to aliphatic chain
oxidation productsii-it is not involved with the excretion of CO^* This
is supported by the observation that the rate constants for exchange
k12
between the central and peripheral compartments (central peripheral)
21
are not different, even at the single standard deviation level.
Similarly, ss which may indicate a static distribution of the
parent carbamate after the initial 0 6 -phase is complete. It is worth 
noting that there are several possible pathways for the cleavage of the 
carbamate group to yield CO^t
Y
Central
compartment
(plasma)
Distribution
( 0 6 -phase) *
Ae-act + Be"P- A t
Total amount of 
parent compound in 
this compartment only 
during the g-pnase is
v^.ct. r
dp p
(esterase)
O-dealkylation
(cyt,P450 ‘ 
linked).
NHOH
+NHCH.(CH,,) - .CH 0; CNH
3 2* -1 | H
OH 0
14,CO,2
ch3(ch2)x -1.cho
+ NH214C00H
I
14co2 +  NH3
In addition, Dahl et al (1978) have suggested that ethyl carbamate 
may form an epoxide.
14The lag time can be seen as the period taken for C02 to equilibrate
with C02 produced by intermediary metabolism (glycolysis, Krebs cycle,
etc.), its duration varying inversely with the rate of hydrolysis of
14the parent carbamate; the C02 excretion occuring after the steady
14state has finished is probably due to elimination of C02 from the
body tissues. The steady state occurs after equilibration of the 
14system with C02»
14Having been produced in the peripheral tissues, the CO^ is
transported by the normal physiological process - ie. approximately
73% in plasma and 27% in erythrocytes (Lambersten, 1974). One
reason why minimal change in total plasma radioactivity has been
14
seen despite such a high proportion of the CO^ being carried in
the plasma may be because blood was sampled from the carotid artery - 
14any CO^ would have been cleared from the blood during its passage 
through the lungs just prior to its recirculation through the 
carotid artery.
A preliminary experiment was performed in which cannulae were placed
in both the inferior vena cava (just above the level of the input of
the hepatic vein) and the right carotid artery. No statistically
14significant fall in C-activity in the plasma across the lungs 
was found, although activity in the vena cava was consistently 
higher than that in the carotid artery.
It can be seen that the plasma half life of elimination of ethyl 
carbamate is disproportionately long compared to the other three 
carbamates. This is perhaps because it is metabolised by a 
different route from the others. Boyland and Nery (1965), Boyland 
et al (1963), Boyland and Rhoden (1949) and Nery (1968) showed that 
about 5 - 8% of a dose of ethyl carbamate (urethane) is metabolised 
to N-hydroxyurethane which in turn gives rise to various degradation 
products of the conjugation of this with glutathione. Ethyl carbamate 
has negligible affinity for cytochrome (Al-Gailany et al, 1978
and Houston, 1973). The other carbamates, however, have a measurable
affinity for cytochrome and are rapidly oxidized to hydroxy-alkyl and
keto-alkyl derivatives: they make even smaller use of the above pathway 
than urethane. For example, about 0.08% of a dose of n-butyl carbamate 
Is excreted as N-hydroxy-n-butyl carbamate within 24 hours (Boyland 
•f Nery, 1965).
The data for the 00^ excretion of the four carbamates has been plotted 
by the "sigma minus*' (£-1) method in figure 6.3. In table 6.1, m is 
the gradient of the slope; t^^-is the half life for elimination; 
r (n) is the correlation coefficient (r) for n data points in the 
regression; c is the intercept on the y axis. Primed values are 
for the terminal part of the n-hexyl carbamate curve. It is 
apparent that, after an initial lag time, elimination of the four 
carbamates as CO^ takes place at virtually the same rate for each
of them. This may indicate that they have a single rate limiting
/■
pathway for excretion as CO^ which is common to them all. For 
example, hydrolysis of alkyl carbamates is thought to proceed as 
follows (Kuhr and Dorough, 1976):
R - 0C0.HH2 + OH’ ; = ^  [r - OCO.n’h] + H20i
R - 0C * NH
L °”
R.O’ + HCNO
HCNO + H20 --> NH2C00H — NH^ + C02
It is interesting that in the metabolism of two N-methyl aromatic 
insecticidal carbamates, landrin and carbaryl, Houston (1973) found 
rate constants of -0.4374 hr * and -0.3918 hr * respectively for 
their elimination as CO^* These values are very similar to those 
for the N-unsubstituted aliphatic carbamates reported here (the 
values m in table 6.1) which further suggests the existence of 
a common hydrolytic pathway.
Figure 6.4 demonstrates the relative amount of each carbamate which
{?
is metallized to either carbon dioxide or urinary metabolites, and 
the dependence of the proportion of each carbamate metabolized by 
these dual pathways on the lipophilicity of the parent carbamate.
This figure also seems to support the hypothesis of a dis-equilibrium 
of the parent carbamates between the peripheral and central compartments 
and indicates that the degree of metabolism by either route seems to 
be controlled by the substrate lipophilicity, probably by determining 
tissue distribution immediately following administration.
FINAL DISCUSSION
It was shown in the introduction that lkP is a free-energy 
related constant (AG « -RTIkP). The logarithm of the rate 
constant or equilibrium constant of any process can be thought 
of as a direct measure of the free energy of that process (Wells, 1968). 
If a linear relationship exists between the rate of absorption (free 
energy of membrane transfer) of a drug and its partition coefficient 
from an aqueous to a lipid phase (free energy of partitioning) then 
from the equation AG * AH - T.AS it can be seen that the entropy 
change,AS, resulting from desolvation of the solute is the major 
driving force for absorption. It must be remembered that AG is 
proportional to -InP; therefore an increasing rate of absorption, 
k^, is indicative of a decreasing free energy of transfer since 
for a linear relationship InP oc In k^ (eg. absorption of the 
n-alkyl carbamates from the stomach and colon).
In considering the binding of the carbamates to cytochrome P4 5 Q 
the law of mass action describes the system at equilibrium 
(ie. when the spectra are recorded)s
K " k ?*5ol - i- (K 1}
®  M  8
where fsj is the substrate concentration.
Thus the linear relationship between affinity of binding (1/K )
and InP shown in Chapter 4 can again be seen to depend ultimately
<
upon the entropy change occur^ .ng as the solute moves from an 
aqueous phase into a lipid one.
In both cases where the absorption rate of the carbamates is 
limited by their lipophilicity (ie. the small intestine and the 
urinary bladder) a hydrophilic barrier has been demonstrated on 
the luminal side of the membrane. This consists of the glycocalyx 
and unstirred layer in the case of the small intestine and, in the 
urinary bladder, either Tween 80 (a non-ionic detergent), where this 
has been added or a mucopolysaccharide layer.
The latter has a smaller effect on k^ than Tween 80, though in both
cases an unstirred layer may also be present. In both these cases then,
AG passes through a minimum (at the peak of the Ink v. InP plot) anda
then starts to increase with increasing partition coefficient. Since 
the entropy change on desolvation is constant for a particular carbamate, 
a relatively positive enthalpy change must account for the increase in 
AG (ie, decreasing k ) on ascending the series (AG * Ah - T.As), Enthalpy 
can be equated with the activation energy necessary to remove the solute 
molecules from the aqueous phase into the membrane. Obviously the 
ehthalpy change required to move a lipophilic molecule from an aqueous 
phase into a hydrophilic layer (eg. glycocalyx) will be greater than 
that needed to move it directly into a lipid phase (ie. the membrane). 
Differences in absorption rates of a particular carbamate from one 
membrane to another can be accounted for by variations in
blood flow rate or luminal surface area between membranes.
In this way drug absorption or binding, and more complicated processes 
compounded of these events such as drug metabolism and pharmacokinetics 
which, in the case of non-electrolytes which are not transported by an
active or facilitated process^are highly dependent upon substrate 
lipophilicity can be seen to be controlled by the thermodynamic 
properties of the system.
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Table 1. Urinary coproporphyrin excretion by rats given various alkylating agents
compared with controls
Dose Day of Maximum daily excretion
(mg/kg maximal (in relation to control
body wt.) excretion 1 values =  1)
Diethylnitrosamine 200 4 6.0
Monocrotaline 130 4 2.3
T-2 toxin 3 4  5.0
Ethylmethanesulphonate 400 2 4.5
Second dose of ethyl- 400 2 4.5
methanesulphonate 
Aq. ethanol (20%) 400 3 1.3
-Controls (untreated) —  —  . 1 . 0
the stage of insertion of the metal iron, which must be in the ferrous state. Among 
the possibilities by which alkylating entities could affect this process may be included the 
substitution of the nitrogen atom(s) of pyrrole, as in the case of chemical alkylations 
in vitro of octaethylporphyrin (Jackson &  Dearden, 1973). This may cause overcrowding 
in the tetrapyrrole ring of porphyrin. Alkylation of thiol groups that are possibly involved 
in the action of haem synthetase (ferrochelatase), may also affect the insertion of the 
Fe2+ ion. Depending on the size and shape, and on the site of release of the various alkyl­
ating entities, various receptor groups, especially in coenzymes, would be substituted 
to different extents (Schoental, 1976).
It  is worth recalling that porphyria has been described in pellagra and in deficiencies 
of certain B vitamins (nicotinic acid and pantothenic acid) (Bicknell &  Prescott, 1948); 
this seems also to indicate a possible involvement of coenzyme in the mechanism of 
this disorder.
The present findings of increased excretion of porphyrins in the urine of rats given 
several types of chemical carcinogens raises the problem of the possible relation of this 
action to carcinogenic activity and requires further studies.
We thank Dr. Valda Craddock for the gift of ethylmethanesulphonate, the Medical Research 
Council Laboratory Animals Centre, Carshalton, for the supplies of the rats, and Miss S. 
Spencer and Mr. R. Edgar, Royal Veterinary College, for excellent care of the animals and the 
collection of the urine from the rats.
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De Matteis, F. (1978) Handb. Exp Pharmakol. 44,129-155
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Absorption of Drugs from the Urinary Bladder
N . S. E. SARG ENT,* D . G. U PSH A LLf and J. W. BRIDGES?
* D epartm ent o f  Biochem istry and f Institute o f  Industrial and Environm ental H ealth  
and Sa fe ty , University o f  Surrey, Guildford, Surrey, U.K., and \T h e  M edical 
Division, Chemical D efence Establishment, Porton Down, Porton, W ilts., U.K.
A  series of n-alkyl carbamates has been used previously to characterize the role of lipo­
philicity in such biological systems as the passage of drugs across the intestinal wall, 
binding to serum albumin and cytochrome P-450 and metabolism (Houston, 1973;
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Wood, 1977). In  this study the same series of carbamates has been used to define the role 
of lipophilicity in the absorption of drugs from the urinary bladder.
Female Wistar albino rats (180-230g) were anaesthetized with pentobarbitone sodium 
and their ureters ligated and urethras cannulated. n-Alkyl [I4C]carbamates dissolved 
in 0.1 M-citric acid/0.2M-disodium hydrogen phosphate buffer, pH 6.4, in a concentration 
of 5 mM were instilled intravesically in a volume of 1 ml/kg body weight. [Ethyl and propyl 
carbamates were dissolved in buffer alone; butyl, pentyl and hexyl carbamates were 
dissolved in 20% (v/v) propan-1,2-diol in buffer and octyl and decyl carbamates in 5% 
(v/v) Tween 80 in buffer.] Samples (approx. 10/d) were withdrawn from the bladder via 
the urethral cannula every 5min for 30min and counted in a liquid-scintillation counter. 
'Water flux in the presence of unlabelled carbamates was determined by measuring the 
rate of dilution of 3H 20  within the bladder lumen by influx of H 20  from the plasma 
across the bladder wall and by measuring the rate of loss of 3H 20  from the bladder lumen 
compared with the non-absorbed marker poly[14C]ethylene glycol 4000. Net volume 
change was determined by following the specific radioactivity of poly[I4C]ethylene 
glycol 4000 throughout the |h  experimental period.
The disappearance of carbamates from the bladder obeyed first-order kinetics, indi­
cating absorption to be by simple diffusion. This was supported by finding that the rate 
of loss of butyl carbamate was unaffected by either a hundred-fold change in its concen-. 
tration (0.5-50mM) or the simultaneous presence of a tenfold molar excess of propyl 
carbamate. The degree of binding of the carbamates to the bladder wall at the end of the 
absorption period was less than 1.6% of the total administered dose in all cases. The rate 
of water flux across the bladder wall was not significantly altered by the presence of the 
carbamates, nor did a net flux of water occur in either direction.
The solubilizing additive propan-1,2-diol did not affect the rate of absorption of the 
carbamates; 5% (v/v) Tween 80 did not affect the absorption rate of ethyl carbamate but 
decreased that of octyl carbamate by about 75%. The reduction of the absorption rate by 
Tween 80 is probably due to the formation of an additional hydrophilic barrier which 
was demonstrated histologically on the luminal side of the bladder wall.
The rate of absorption of the carbamates was limited by their hydrophilicity, but with 
the more lipophilic carbamates the absorption rate reached a constant value with a half- 
life for loss of approx. lOmin. The rates of absorption of these carbamates from the 
bladder are comparable with their absorption from small intestine (Houston, 1973; 
Wood, 1977) and colon (Wood, 1977).
Clayson &  Cooper (1970) reported the presence of sulphatase and ^-glucuronidase in 
the mucosal epithelium of the bladder wall which are capable of hydrolysing drug 
sulphates and glucuronides. It  is clear that conjugates of lipophilic compounds that can 
be hydrolysed by these enzymes may be readily recirculated via absorption from the 
bladder back into the systemic circulation.
N. S. E. S. acknowledges the financial support of the Procurement Executive, Ministry of 
Defence.
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RAPID ABSORPTION FROM THE URINARY BLADDER OF A SERIES 
OF n-ALKYL CARBAMATES: A ROUTE FOR THE RECIRCULATION OF .
DRUGS
J.W. BRIDGES, N.S.E. SARGENT* & D.G. UPSHALL*
Institute of Industrial-and Environmental Health and Safety,
University of Surrey, Guildford and the Chemical Defence Establishment*,
Porton Down, Nr. Salisbury, Wilts
1 The rate of loss of a series of n-alkyl carbamates from the lumen of the urinary bladders of 
female rats has been studied.
2 The rate of loss obeys first order kinetics and was not affected by water flux across the bladder 
wall nor by binding of the carbamates to it.
3 The rate of loss of octyl carbamate was reduced by about 76% by the presence of 5% Tween 
80. Histological evidence- indicates that this may be due to the formation of a thin luminal lining 
which may be adsorbed Tween 80 or mucopolysaccharide material.
4 The absorption rate of the carbamates was limited by their hydrophilicity but reached a plateau 
for the more lipophilic homologues with a half life for loss of approximately 10  min.
5 The implications of these results with regard to the recirculation of unmetabolized drugs and 
hydrolysed conjugates of drugs, the systemic absorption of intravesically applied cancer chemothera­
peutic agents and bladder wall permeability to carcinogens are discussed.
Introduction
Previous work has shown that the urinary bladders 
of rabbits, dogs and humans are slightly permeable 
to inorganic ions such as I - , N a +, C l- , K +, H +, 
Br~ and PO4 -  (Read &  Care, 1954; Maluf, 1955; 
Englund, 1956; Hlad, Nelson &  Holmes, 1956; 
Andrysek &  Schuck, 1959; Rapoport, Nicholson &  
Yendt, 1960). Organic molecules such as glycine, 
glucose and tryptophan and some of its metab­
olites are extensively reabsorbed from the urinary 
bladder of the mouse within 24 h of administration 
(Bryan, Morris &  Brown, 1965; Morris &  Bryan, 
1966).
Yeates (I960), using a'series of sulphonamides, 
found that there was a molecular weight limit of 2 0 0  
beyond which these compounds were not absorbed 
from the bladder; the influence of other molecular 
features such as lipophilicity and dissociation con­
stant on absorption were not considered.
Although both 5-fluorouracil and the bis-pyri- 
dinium oxime HS-6  are small hydrophilic molecules 
the former is not absorbed from the bladder (Bess- 
man, Johnson &  Goldin, 1975) whilst the latter is 
well absorbed following its intravesical instillation 
(Kepner &  Wolthuis, 1978).
Little or no absorption of high molecular weight 
compounds such as doxorubicin hydrochloride 
(Banks, Pontes, Izbicki &  Pierce, 1977), neomycin,
0007-1188/79/060283-07 SOI.00
polymyxin B, bacitracin (Chamberlain &  Needham,
1976) cytosine arabinoside or adriamycin (Bessman, 
et al., 1975) occurs.
Borzelleca (1963; 1965) demonstrated that nicotine . 
is absorbed from rat and rabbit bladders and that 
the extent of this absorption is dependent on the 
degree of ionisation of nicotine in accordance with 
the pH-partition hypothesis.
Jones 8c Svvinney (1961) and Bessman, et al. (1975) 
reported that thiotepa (triethylene thiophosphora- 
mide) was absorbed from the urinary bladders of 
humans and rats and the latter workers showed that 
the rate of absorption of thiotepa increased as the 
asymmetric unit membrane (Vergara, Longley &  
Robertson, 1969; Hicks &  Ketterer, 1969; 1970; 
Warren &  Hicks, 1970) became de-differentiated after 
feeding the rats with the bladder carcinogen N-[4- 
(5-nitro-2-furyl)-2-thiazolyl]formamide.
Systematic studies on the influence of factors such 
as lipophilicity and molecular connectivity index on 
bladder absorption have not been described pre­
viously. The present studies were initiated by the rea­
lisation that urethane (ethyl carbamate) was being 
absorbed from the bladder subsequent to its clearance 
by the kidneys. The series of aliphatic carbamates 
selected has previously been used to elucidate the 
absorption characteristics of the rat intestine; thus a
©  Macmillan Journals Ltd 1979 .
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direct comparison of the absorptive properties of the 
intestine and bladder can be made.
Methods
Ethyl[, 4C]-carbamate (sp. act. 31.4 pCi/pmol; purity 
>98.9%) was obtained from Fluorochem Ltd., Glos- 
sop, Derby. The other 14C-labelled carbamates were 
synthesized in the Chemistry Division, C.D.E. Porton 
by condensation of [ 14C]-urea with the appropriate 
n-aliphatic primary alcohol, sp. act 0.5 to 1.65 
pCi/pmol; purity >99% (Wood, 1977).
Carbamates were made up to a concentration of 
5 pmol/ml, 0.2-0.4 pCi/ml in 0.17 m citric acid- 
disodium hydrogen phosphate buffer pH 6.4 (Analar
grade; BDH) with various solubilizing additives as 
shown in Tables 1 and 2. Tween 80 was obtained 
from Hopkin &  Williams, propan-1,2-diol (Analar 
grade) from BDH and the detergent Metapol from 
Durham Chemicals Distributors Ltd.
Water flux rates in the presence of various carba­
mate solutions were estimated as follows: non-radio- 
labelled carbamates were dissolved in 0.17 m citrate- 
phosphate buffer pH 6.4 and to these were added 
tracer amounts of tritiated water ( [3H ]-H 20 )  and 
[ 14C]-polyethylene glycol 4000 ( [ ,4C]-PEG 4000) 
(Radiochemical Centre Ltd., Amersham) in an activity 
ratio, 3H /14C, of approximately 5.
Female Wistar albino rats (180 to 230 g) guaran­
teed free of the nematode bladder parasite Trichoso- 
moides crassicuda (Clayson &  Cooper, 1970) were
Table 1 Relationship between partition coefficient (P) and first-order atom molecular connectivity index (!x) 
of several carbamates and their absorption from the bladder
%  dose bound to
Cone. bladder wall after
Carbamate Dissolved in (mxt) K„ min~l T 2(min) n c P ‘x 30 min
Ethyl Citrate-phosphate 5 -0.0236 29.4 5 4.49 0.7 2.414 1.29 ± 0.23
+0.0078 ' ±7.3 + 0.12
Propyl Citrate-phosphate 5 -0.0354 19.6 4 4.44 2.3 2.914 1.39 ± 0.74
+0.0019 + 1.0 +0.05
Butyl 20% Propan-1,2-diol 5 -0.0639 10.8 . 4 4.66 7.1 3.414 0.64 ± 0.37
in citrate-phosphate +0.0014 + 0.2 ± 0.12
Pentyl 20% Propan-1,2-diol 5 -0.0516 13.4 4 4.59 22.5 3.914 0.23 ± 0.09
in citrate-phosphate ±0.0063 + 1.4 +0.08
Hexyl 20% Propan-1,2-diol 5 -0.0750 9.2 4 4.60 70.8 4.414 0.76 ± 0.36
in citrate-phosphate ± 0.0126 + 1.3 ±0.04
Octyl 5% Tween 80 5 -0.0151 45.9 4 4.51 700 5.414 1.26 ± 0.20
in citrate-phosphate + 0.0026 ±6.7 ± 0.02
Decyl 5% Tween 80 5 -0.0086 80.6 4 4.58 7000 6.414 1.55 ±0.27
in citrate-phosphate +0.0019 + 14.6 + 0.02
Ethyl 20%  propan-1,2-diol 5 -0.0293 23.7 3 4.55 —
in citrate-phosphate +0.0059 +4.0 +0.08
Ethyl 5% Tween 80 5 -0.0324 21.4 3 4.55 —
in citrate-phosphate ±0.0087 +4.5 ± 0.11
Butyl Citrate-phosphate 5 -0.0588 11.8 5 4.66 0.73 ± 0.19
+0.0052 + 1.0 + 0.08
Octyl Citrate-phosphate 0.5 -0.0621 11.2 4 4.33 1.23 ± 0.28
+0.0142 + 2.1 +0.07
Butyl 20% Propan- 1,2-diol 0.5 -0.0698 9.9 3 4.52 —
in citrate-phosphate +0.0199 + 2.2 +0.03
Butyl 20% Propan-1,2-diol 50 -0.0626 11.1 3 4.54 — ,
in citrate-phosphate +0.0115 + 1.7 +0.08
Butyl 20%  propan-1,2-diol 5 -0.0765 9.1 4 4.68 —
in citrate-phosphate + 0.0232 + 2.1 + 0.16
in presence of
50 m M  propyl
carbamate
Carbamates used and the conditions under which they were studied are shown, together with rates of loss 
from the bladder (/£„, min-1), half life of loss (7^ , min), number of experiments (n), intercept an the y-axis 
(c) and %  dose bound to the bladder wall after 30 min. Results are means + s.d.
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used Anaesthesia was induced by ether and main­
tained with intraperitoneal pentobarbitone sodium, 
60 mg/ml (May &  Baker Ltd). A midline incision 
was made on the abdomen, both ureters were 
ligated with cotton and the abdomen closed with 
suture clips except for a small length over the 
bladder. The urethra was cannulated with PP25 
polythene tubing (Portex), and the bladder was 
emptied by gentle pressure on the bladder wall. This 
cannula was then removed and replaced with another 
which was secured by a cotton ligature around the 
urethra.
Solutions within the bladder lumen were kept well 
stirred both by removing small amounts into the 
urethral cannula and rapidly pushing them back in 
again and by the muscular contractions of the bladder 
wall.
Solutions (always 1 ml/kg body weight) were in­
stilled into the bladder-and samples withdrawn into 
preweighed plastic scintillation vials (Sterilin Ltd.), 
and reweighed. The volume of the sample was deter­
mined from the weight difference assuming the 
specific gravity of the sample to be 1.00. Scintillation 
counting medium was made up as follows: toluene: 
metapol, 2:1, plus 0.55% w/v 2,5-diphenyloxazole 
(PPO, Koch-Light Ltd). For double labelled counting 
0.05% w/v l,4-di-2-(4-methyl-5-phenyloxazolyl) ben­
zene (di Me POPOP: Koch-Light Ltd.) was also 
added; 4 ml of this medium was added to each vial 
which was then counted in an LKB Wallac 1210 
Ultrobeta programmable liquid scintillation counter. 
Counting efficiency was determined by an automatic 
external standard using a quench curve established 
by counting known amounts of tritium or ,4C activity 
in the presence of increasing amounts of carbon tetra­
chloride.
Blood levels of 14C were determined following the 
intravesical instillation of 5 mM [ ,4C]-butyl carba­
mate in 20% propan-1,2-diol in 0.17 m citrate-phos­
phate buffer pH 6.4 (1 ml/kg). Blood was sampled 
from the right carotid artery and immediately centri­
fuged at 2000 g for 2 min. Plasma samples (0.1 ml) 
were added to 1 ml NCS solubiliser (Amersham- 
Searle) in glass vials and counted as above, after 
allowing for the attenuation of chemiluminescence by 
storing the samples in the cold and dark for at least 
3 h.
The degree of binding to the bladder wall was 
determined by removing the entire bladder (approxi­
mately 75 mg) at the end of the 30-min absorption 
period and washing it rapidly (10 to 15 s) twice in 
ice-cold 0.9% w/v NaCl solution (saline), blotting it 
dry and solubilizing in 1 ml Soluene 100 (Packard 
Ltd). The samples were bleached with 0.2 ml isopro­
panol (BDH Ltd.) and 0.1 ml 100 volume hydrogen 
peroxide. Samples were counted and then 10 pi stan­
dard [ ,4C]-hexadecane (Radiochemical Centre Ltd)
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Time (min) after carbamate instillation
Figure 1 Typical semi-logarithmic plots showing the 
rate of loss of ethyl, butyl and decyl (in the presence 
of 5% Tween 80) carbamates from the bladder lumen. 
Ordinate scale: %  carbamate remaining in bladder 
lumen; abscissa scale: time (min) after instillation of 
carbamate solution into the bladder lumen. Mean 
values arc shown: vertical lines indicate s.d.
was added to each vial and recounted to estimate 
the counting efficiency.
To examine the possible effect of Tween 80 on the 
bladder wall, a solution of 5% Tween 80 in 0.17 m 
citrate-phosphate buffer pH 6.4 (1 ml/kg) was instilled 
intravesically into each of three rats. Three control 
rats received 0.17 m citrate-phosphate buffer alone. 
After 30 min the bladders were cut out, carefully blot­
ted dry (avoiding touching the mucosa) and sectioned 
in half longitudinally with a scapel blade. One half 
from each rat was fixed in 10% formyl saline for 6  
days, progressively dehydrated and embedded in wax; 
6  pm sections were cut in a microtome, floated on 
warm water and dried on slides in an oven at 37 C. 
Sections were dewaxed in xylene, rehydrated in dilute 
alcohol followed by water and stained in either 
haematoxylin and eosin or periodic acid-Schiff re­
agent.
Partition coefficients were determined by Hous­
ton (1973) using octan-l-ol and 0.1 m phosphate 
buffer pH 7.4 at 37°C. The value for decyl carbamate 
was determined by linear extrapolation of a plot of 
the' number of carbon atoms in the alkyl side chain 
against log partition coefficient for the series methyl 
to n-octyl carbamate.
The first order atom molecular connectivity indices, 
lX, were determined according to Kier &  Hall (1977).
bj.p. 66/2—1
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Figure 2. Plot of log partition coefficient (abscissa 
scale) against log first order diffusion coefficient, K.„ 
(ordinate scale) for the straight chain carbamates in the 
stomach, small intestine, colon and urinary bladder.. 
Mean values are shown; vertical lines indicate s.d. The 
dashed line branching from the solid line for the blad­
der plot follows the absorption rate constants for octyl 
and decyl carbamates in the presence of 5% Tween 80.
Results
First order rate constants for the loss of the carba­
mates from the bladder lumen were calculated by 
linear regression analysis by the method of least 
squares of a graph of;
log ey =  c — K.J (see Figure 1)
where y =  %  original carbamate concentration 
remaining in bladder after time, r, c =  intercept on 
the y-axis and K a =  rate of loss of carbamate from 
the bladder lumen.
In Figure 2 the relationship between partition co­
efficient and rate constant for loss of carbamates from 
the bladder is shown and compared with carbamate 
absorption from the stomach (Houston, 1973), colon 
(Wood, 1977) and small intestine (Houston, 1973; 
Wood 197.7). The data points and standard deviations 
of these earlier determinations have been omitted for 
the sake of clarity.
Contrary to the conclusions of Hicks (1966) it has 
been found that water readily passes across the blad­
der wall in both directions. The presence of carba­
mate did not appear to affect net water flux to any 
significant extent (see Table 2 and Figure 3).
The rates of water flux are presented as percentage 
original bladder volume (1  ml/kg) transported per 
minute and were calculated as follows; Efflux of 
[ 3H ]-H 20  is indicated by loss of 3H  relative to 
changes in [ l4C]-PEG 4000, which is a non-absorbed
Net flux
110
100 - \N
N90
80
70 Efflux
6 0
Influx
5 0
40
L  1_
100 20
Time (min) after octyl carbamate instillation
Figure 3. Typical plots of the rates of water influx, 
efflux, and net flux across the bladder wall, in this case 
under the influence of intravesical 5 m M  octyl carba­
mate in 5% Tween 80 in 0.17 m citrate-phosphate buffer 
pH 6.4. Mean values are shown; vertical lines indicate 
s.d.
non-diffusible indicator, i.e.;
(3H /14C) t
( H / C) t =  0
(N.B. Influx of water will dilute 3H and 14C to an equal 
extent and so not affect the ratio).
Influx of water: the specific activity of the instilled 
solution is not affected by efflux of [ 3H ]-H 20  so any 
change in specific activity must be due to an influx of 
H 20  diluting the [ 3H ]-H 20 .
The net volume change or flux is proportional to
1
[  C-PEG 4000],=,
therefore the fractional volume change
cuq,.;
The % original volume in Table 2 is the mean ±s.d. 
for all the values
[ 14C ] ,  = o y  i n n
p c u  x 100
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for each carbamate solution tested. Preliminary ex­
periments showed that for the first 40 to 50 min water 
flux rates obey zero order rate kinetics but this 
becomes a pseudo first order rate as equilibrium is 
approached between 3H O H  in the plasma and blad­
der.
The presence of 5% Tween 80 (a non-ionic surfac­
tant: polyoxyethylene sorbitan mono-oleate) reduced 
the rate of loss of octyl carbamate by approximately 
76% (P <  0 .0 0 1 ) but did not affect the rate of loss 
of ethyl carbamate (Table 1).
Examination of Figure 2 reveals that the rate of 
loss of the more hydrophilic carbamates is limited 
but that with increasing lipophilicity the rate of loss 
becomes constant.
Discussion
The first-order rate of loss of-the carbamates from 
the bladder, which was preserved over a 100  fold dif­
ference in the concentration of butyl carbamate and 
was unaffected by the further addition of a 10 fold 
molar excess of propyl carbamate, demonstrated that 
carbamate disappearance occurs by simple diffusion. 
This is also the case for carbamate loss from the 
stomach, small intestine and colon (Houston, 1973; 
Houston, Upshall &  Bridges, 1974; 1975; Wood, 
Upshall &  Bridges, 1978).
Houston (1973) observed that the gastric absorp­
tion of octyl carbamate was reduced by 5% Tween
80. This concentration of Tween 80 is well in excess 
of its critical micellar concentration, and 98% of the 
octyl carbamate present was incorporated into the 
micelles under these conditions (Houston, 1973). 
Houston (1973) surmised that the Tween 80 effect on 
the permeability of the gastric mucosa might be more 
significant than its influence in retarding octyl carba­
mate availability to the mucosa. The fact that periodic 
acid-Schiff reagent stained the luminal edge of the 
bladder epithelium much more intensely in the pres­
ence than in the absence of Tween 80 supports this 
notion of a direct effect of Tween 80 on absorptive 
surfaces. The increased staining may be due to the 
reaction of Tween 80 adsorbed onto the epithelial sur­
face with the periodic acid-Schiff reagent or stimu­
lation of the production of mucopolysaccharides of 
the epithelium by Tween 80. Either of these possibili­
ties would be expected to reduce the rate of loss of 
a hydrophobic molecule such as octyl carbamate but 
would have a minimal effect on the rate of loss of 
a hydrophilic molecule such as ethyl carbamate, as 
is the case.
It is possible to understand how a detergent may 
alter the permeability of the membrane if the deter­
gent molecules are seen as being orientated so that 
their lipophilic components are located towards or 
embedded in the luminal membrane with the hydro­
philic part of the molecule directed towards the lumen 
of the bladder. In this way compounds would have 
to traverse an additional hydrophilic barrier in order
Table 2 Determination of rates of water influx, efflux and net flux across the bladder epithelium in the absence 
and presence of carbamates
Concentration Influx Efflux N et flux %  Original
Compound Dissolved in (mM) {%/miri) (%/min) {%/min) volume n
Control 0.17 M citrate- _ 1.12 ± 0.64 0.99 ± 0.76 0.16 ± 0.51 100.3 4
phosphate only + 11.4
Ethyl Citrate- 5 1.40 ± 0.09 1.35 ± 0.21 0.30 ± 0.26 110.2 3
carbamate phosphate + 10.3
Butyl 20% Propan 5 1.63 ± 0.36 1.58 ± 0.38 0.90 ± 0.53 104.1 4
carbamate 1,2-diol in ±13.1
citrate-
phosphate
Octyl 5% Tween 80 5 1.98 ± 0.27 2.09 ± 0.45 0.06 ± 0.51 109.0 4
carbamate in citrate- ± 11.2
phosphate
Butyl Citrate 5 1.21 ± 0.48 0.93 ± 0.52 0.70 ± 0.21 109.1 4
carbamate phosphate + 12.2
Octyl Citrate- 0.5 2.04 ± 0.27 ' 2.03 ± 0.67 0.16 ± 0.70 109.9 3
carbamate phosphate + 8.9
The %  of original volume found at the end of each experiment and the number of experiments performed 
(n) are shown. Results are means ± s.d.
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Figure 4. Graph showing the rate of appearance of 
butyl carbamate equivalents in the plasma after intrave­
sical instillation of [14C]-butyl carbamate (5 pmol/kg). 
Mean values are shown; vertical lines indicate s.d.; 
n = 5.
to cross the membrane and so the absorption rate 
of lipophilic compounds may be retarded.
Comparison of the rates of diffusion of carbamates 
across the parts of the gastrointestinal tract with that 
of the bladder shows that the bladder wall is at least 
as permeable as the small intestine and colon to these 
straight chain carbamates and this is supported by 
the rapid appearance of 14C in the plasma following 
intravesical instillation of [ 14C]-butyl carbamate 
(Figure 4).
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